Özgeçmiş - Prof. Dr. Hasan Herken


A	YAYINLAR, ATIFLAR VE FAALİYETLER
a.	1.Title: A magnetic resonance imaging study of the adhesio interthalamica in schizophrenia Author(s): Erbagci H, Yildirim H, Herken H, Gumusburun E Source: SCHIZOPHRENIA RESEARCH 55 (1-2): 89-92 MAY 1 2002 Document Type: Article Language: English Cited References: 14 Times Cited: 6 2.Title: Association of T102C polymorphism of the 5-HT2A receptor gene with pyschiatric status in fibromyalgia syndrome Author(s): Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B Source: RHEUMATOLOGY INTERNATIONAL 21 (2): 58-61 OCT 2001 Document Type: Article Language: English Cited References: 12 Times Cited: 12 3.Title: Significance of the catechol-O-methyltransferase gene polymorphism in migraine Author(s): Erdal ME, Herken H, Yilmaz M, Bayazit YA Source: MOLECULAR BRAIN RESEARCH 94 (1-2): 193-196 OCT 19 2001 Document Type: Article Language: English Cited References: 13 Times Cited: 3 4.Title: Possible association of temporomandibular joint pain and dysfunction with a polymorphism the serotonin transporter gene Author(s): Herken H, Erdal E, Mutlu N, Barlas O, Cataloluk O, Oz F, Guray E Source: AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS 120 (3): 308-313 SEP 2001 Document Type: Article Language: English Cited References: 34 Times Cited: 8 5.Title: Association of the T102C polymorphism of 5-HT2A receptor gene with aura in migraine Author(s): Erdal ME, Herken H, Yilmaz M, Bayazit YA Source: JOURNAL OF THE NEUROLOGICAL SCIENCES 188 (1-2): 99-101 JUL 15 2001 Document Type: Article Language: English Cited References: 15 Times Cited: 8 5.Title: Serum IL-1 beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment Author(s): Erbagci AB, Herken H, Koyluoglu O, Yilmaz N, Tarakcioglu M Source: MEDIATORS OF INFLAMMATION 10 (3): 109-115 JUN 2001 Document Type: Article Language: English Cited References: 32 Times Cited: 19 6.Title: Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis Author(s): Herken H, Erdal ME Source: PSYCHIATRIC GENETICS 11 (2): 105-109 JUN 2001 Document Type: Article Language: English Cited References: 19 Times Cited: 29 7.Title: Significance of serotonin transporter gene polymorphism in migraine Author(s): Yilmaz M, Erdal ME, Herken H, Cataloluk O, Barlas O, Bayazit YA Source: JOURNAL OF THE NEUROLOGICAL SCIENCES 186 (1-2): 27-30 MAY 1 2001 Document Type: Article Language: English Cited References: 14 Times Cited: 23 8.Title: An apparently dominant bipolar affective disorder (BPAD) locus on chromosome 20p11.2-q11.2 in a large Turkish pedigree Author(s): Radhakrishna U, Senol S, Herken H, Gucuyener K, Gehrig C, Blouin JL, Akarsu NA, Antonarakis SE Source: EUROPEAN JOURNAL OF HUMAN GENETICS 9 (1): 39-44 JAN 2001 Document Type: Article Language: English Cited References: 36 Times Cited: 16 9.Title: Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation ape increased in different forms of schizophrenia Author(s): Herken H, Uz E, Ozyurt H, Sogut S, Virit O, Akyol O Source: MOLECULAR PSYCHIATRY 6 (1): 66-73 JAN 2001 Document Type: Article Language: English Cited References: 54 Times Cited: 57 10.Title: The A218C polymorphism of tryptophan hydroxylase gene and migraine Author(s): Erdal N (Erdal, Nurten), Herken H (Herken, Hasan), Yilmaz M (Yilmaz, Mustafa), Erdal E (Erdal, Emin), Bayazit YA (Bayazit, Yidirim A.) Source: JOURNAL OF CLINICAL NEUROSCIENCE 14 (3): 249-251 MAR 2007 Document Type: Article Language: English Cited References: 18 Times Cited: 0 11.Title: Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia Author(s): Yilmaz N (Yilmaz, Necat), Herken H (Herken, Hasan), Cicek HK (Cicek, Huelya Kanbur), Celik A (Celik, Ahmet), Yurekli M (Yuerekli, Muhittin), Akyol O (Akyol, Oemer) Source: MEDICAL PRINCIPLES AND PRACTICE 16 (2): 137-141 2007 Document Type: Article Language: English Cited References: 27 Times Cited: 0 12.Title: Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: Impact of antidepressant treatment Author(s): Herken H (Herken, Hasan), Gurel A (Gurel, Ahmet), Selek S (Selek, Salih), Armutcu F (Armutcu, Ferah), Ozen ME (Ozen, Murat Eren), Bulut M (Bulut, Mahmut), Kap O (Kap, Ozlem), Yumru M (Yumru, Mehmet), Savas HA (Savas, Haluk Asuman), Akyol O (Akyol, Omer) Source: ARCHIVES OF MEDICAL RESEARCH 38 (2): 247-252 FEB 2007 Document Type: Article Language: English Cited References: 36 Times Cited: 0 13.Title: The protective effects of omega-3 fatty acids against MK-801-induced neurotoxicity in prefrontal cortex of rat Author(s): Ozyurt B (Ozyurt, Birsen), Sarsilmaz M (Sarsilmaz, Mustafa), Akpolat N (Akpolat, Nusret), Ozyurt H (Ozyurt, Huseyin), Akyol O (Akyol, Omer), Herken H (Herken, Hasan), Kus I (Kus, Ilter) Source: NEUROCHEMISTRY INTERNATIONAL 50 (1): 196-202 JAN 2007 Document Type: Article Language: English Cited References: 59 Times Cited: 1 14.Title: Hippocampal volume in schizophrenia and its relationship with risperidone treatment: A stereological study Author(s): Savas HA, Unal B, Erbagci H, Inaloz S, Herken H, Canan S, Gumusburun E, Zoroglu SS Source: NEUROPSYCHOBIOLOGY 46 (2): 61-66 2002 Document Type: Article Language: English Cited References: 40 Times Cited: 7 15.Title: Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: Impact of past episodes Author(s): Savas HA, Gergerlioglu HS, Armutcu F, Herken H, Yilmaz HR, Kocoglu E, Selek S, Tutkun H, Zoroglu SS, Akyol O Source: WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY 7 (1): 51-55 2006 Document Type: Article Language: English Cited References: 45 Times Cited: 1 16.Title: Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment Author(s): Herken H, Akyol O, Yilmaz HR, Tutkun H, Savas HA, Ozen ME, Kalenderoglu A, Gulec M Source: HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL 21 (1): 53-59 JAN 2006 Document Type: Article Language: English Cited References: 39 Times Cited: 3 17.Title: Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia Author(s): Akyol O, Yanik M, Elyas H, Namli M, Canatan H, Akin H, Yuce H, Yilmaz HR, Tutkun H, Sogut S, Herken H, Ozyurt H, Savas HA, Zoroglu SS Source: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 29 (1): 123-131 JAN 2005 Document Type: Review Language: English Cited References: 39 Times Cited: 6 18.Title: Relationship between alexithymia, dissociation and anxiety in psychiatric outpatients from Turkey Author(s): Tutkun H, Savas HA, Zoroglu SS, Esgi K, Herken H, Tiryaki N Source: ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES 41 (2): 118-124 2004 Document Type: Article Language: English Cited References: 27 Times Cited: 1 19.Title: T102C polymorphism of the 5-HT2A receptor gene may be a ssociated with temporomandibular dysfunction Author(s): Mutlu N, Erdal ME, Herken H, Oz G, Bayazit YA Source: ORAL DISEASES 10 (6): 349-352 NOV 2004 Document Type: Article Language: English Cited References: 15 Times Cited: 3 20.Title: Alexithymic features in migraine patients Author(s): Muftuoglu MN, Herken H, Demirci H, Virit O, Neyal A Source: EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 254 (3): 182-186 JUN 2004 Document Type: Article Language: English Cited References: 28 Times Cited: 1 21.Title: Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia Author(s): Yanik M, Kocyigit A, Tutkun H, Vural H, Herken H Source: BIOLOGICAL TRACE ELEMENT RESEARCH 98 (2): 109-117 MAY 2004 Document Type: Article Language: English Cited References: 37 Times Cited: 2 22.Title: The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder Author(s): Yanik M, Vural H, Tutkun H, Zoroglu SS, Sava HA, Herken H, Kocyigit A, Keles H, Akyol O Source: EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 254 (1): 43-47 FEB 2004 Document Type: Article Language: English Cited References: 40 Times Cited: 4 23.Title: Monoamine oxidase-A gene promoter polymorphism in female migraineurs Author(s): Erdal ME, Herken H, Yilmaz M, Bayazit YA Source: PAIN CLINIC 15 (4): 455-458 2003 Document Type: Article Language: English Cited References: 15 Times Cited: 0 24.Title: Migraine and angiotensin-converting enzyme association in Turkish patients Author(s): Cakmak EA, Cataloluk O, Yoldas T, Arslan A, Herken H, Barlas O, Gorucu S, Yigiter R Source: PAIN CLINIC 15 (4): 473-477 2003 Document Type: Article Language: English Cited References: 14 Times Cited: 0 25.Title: Significance of catechol-O-methyltransferase gene polymorphism in myofacial pain syndrome Author(s): Erdal ME, Herken H, Mutlu MN, Bayazit YA Source: PAIN CLINIC 15 (3): 309-313 2003 Document Type: Article Language: English Cited References: 20 Times Cited: 0 26.Title: The 1438G/A polymorphism of the 5-HT2A receptor gene is associated with aura in migraine Author(s): Erdal ME, Yilmaz M, Herken H, Kocoglu H, Bayazit YA Source: PAIN CLINIC 15 (3): 315-319 2003 Document Type: Article Language: English Cited References: 19 Times Cited: 2 27.Title: Psychophysical responses to experimentally induced heat and cold pain before, during, and after transcutaneous electrical nerve stimulation Author(s): Tulgar M, Tulgar O, Herken H Source: NEUROMODULATION 6 (4): 229-236 OCT 2003 Document Type: Article Language: English Cited References: 14 Times Cited: 1 28.Title: Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive-compulsive disorder Author(s): Erdal ME, Tot S, Yazici K, Yazici A, Herken H, Erdem P, Derici E, Camdeviren H Source: DEPRESSION AND ANXIETY 18 (1): 41-45 2003 Document Type: Article Language: English Cited References: 34 Times Cited: 7 29.Title: Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome Author(s): Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N Source: RHEUMATOLOGY INTERNATIONAL 23 (3): 104-107 MAY 2003 Document Type: Article Language: English Cited References: 15 Times Cited: 18 30.Title: Angiotensin converting enzyme gene polymorphism and its association to Bipolar Affective Disorder in Turkish patients Author(s): Cataloluk O, Nacak M, Savas HA, Tutkun H, Zoroglu SS, Herken H, Barlas O, Ozen ME, Arslan A Source: NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH 10 (3): 129-132 2002 Document Type: Article Language: English Cited References: 20 Times Cited: 0 31.Title: Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia? Author(s): Yanik M, Vural H, Kocyigit A, Tutkun H, Zoroglu SS, Herken H, Savas HA, Koylu A, Akyol O Source: NEUROPSYCHOBIOLOGY 47 (2): 61-65 2003 Document Type: Article Language: English Cited References: 28 Times Cited: 11 32.Title: T102C polymorphisms at the 5-HT2A receptor gene in Turkish schizophrenia patients: A possible association with prognosis Author(s): Herken H, Erdal ME, Erdal N, Aynacioglu S Source: NEUROPSYCHOBIOLOGY 47 (1): 27-30 2003 Document Type: Article Language: English Cited References: 15 Times Cited: 5 *(Yazışma Adresi Hasan Herken) 33.Title: Pathophysiological role of nitric oxide and adrenomedullin in autism Author(s): Zoroglu SS, Yurekli M, Meram I, Sogut S, Tutkun H, Yetkin O, Sivasli E, Savas HA, Yanik M, Herken H, Akyol O Source: CELL BIOCHEMISTRY AND FUNCTION 21 (1): 55-60 MAR 2003 Document Type: Article Language: English Cited References: 43 Times Cited: 9 34.Title: The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia Author(s): Zoroglu SS, Herken H, Yurekli M, Uz E, Tutkun H, Savas HA, Bagci C, Ozen ME, Cengiz B, Cakmak EA, Dogru MI, Akyol O Source: JOURNAL OF PSYCHIATRIC RESEARCH 36 (5): 309-315 SEP-OCT 2002 Document Type: Article Language: English Cited References: 50 Times Cited: 13 35.Title: Absence of association of the serotonin transporter gene polymorphism with the mentally healthy subset of fibromyalgia patients (vol 21, pg 194, 2002) Author(s): Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B Source: CLINICAL RHEUMATOLOGY 21 (4): 351-351 AUG 2002 Document Type: Correction Language: English Cited References: 1 Times Cited: 0 36.Title: The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients The possible role of oxidant/antioxidant imbalance Author(s): Akyol O, Herken H, Uz E, Fadillioglu E, Unal S, Sogut S, Ozyurt H, Savas HA Source: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 26 (5): 995-1005 JUN 2002 Document Type: Review Language: English Cited References: 80 Times Cited: 48 37.Title: Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder Author(s): Zoroglu SS, Erdal ME, Alasehirli B, Erdal N, Sivasli E, Tutkun H, Savas HA, Herken H Source: NEUROPSYCHOBIOLOGY 45 (4): 176-181 2002 Document Type: Article Language: English Cited References: 49 Times Cited: 31 38.Title: Possible role of nitric oxide and adrenomedullin in bipolar affective disorder Author(s): Savas HA, Herken H, Yurekli M, Uz E, Tutkun H, Zoroglu SS, Ozen ME, Cengiz B, Akyol O Source: NEUROPSYCHOBIOLOGY 45 (2): 57-61 2002 Document Type: Article Language: English Cited References: 37 Times Cited: 17 39.Title: Association between the 196G > A (VAL66 MET) and -1360C > T (C-270T) polymorphisms of the brain-derived neurotrophic factor gene and bipolar disorder Author(s): Demiryurek S, Savas HA, Igci M, et al. Source: NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH Volume: 13 Issue: 3 Pages: 125-130 Published: 2006 Times Cited: 0 40.Title: Schizophrenia and angiotensin converting enzyme gene association in Turkish patients Author(s): Virit O, Herken H, Nacak M, et al. Source: NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH Volume: 12 Issue: 4 Pages: 153-158 Published: 2005 Times Cited: 0 41.Title: Oxidative imbalance in obsessive compulsive disorder patients: A total evaluation of oxidant-antioxidant status Author(s): Selek S, Herken H, Bulut M, et al. Source: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY Volume: 32 Issue: 2 Pages: 487-491 Published: FEB 15 2008 42.Title: Alexithymia in patients with fibromyalgia syndrome** Author(s): Madenci E, Herken H, Keven S, et al. Source: TURKIYE KLINIKLERI TIP BILIMLERI DERGISI Volume: 27 Issue: 1 Pages: 32-35 Published: FEB 2007
b.
A.2	1.Title: Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment Author(s): Ozen ME (Ozen, Murat Eren), Yumru M (Yumru, Mehmet), Savas HA (Savas, Haluk A.), Cansel N (Cansel, Neslihan), Herken H (Herken, Hasan) Source: WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY 8 (1): 42-44 2007 Document Type: Article Language: English Cited References: 16 Times Cited: 0 2.Title: An unusual form of self-mutilation: tongue amputation with local anesthesia Author(s): Erdur B (Erdur, Bulent), Turkcuer I (Turkcuer, Ibrahim), Herken H(Herken, Hasan) Source: AMERICAN JOURNAL OF EMERGENCY MEDICINE 24 (5): 625-628 SEP 2006 Document Type: Article Language: English Cited References: 12 Times Cited: 0 3.Title: Associations between Mn-SOD genetic polymorphism and schizophrenia Author(s): Akyol O, Elyas H, Canatan H, Akin H, Yuce H, Yanik M, Namli M, Yilmaz HR, Tutkun H, Herken H, Savas HA, Zoroglu SS, Sogut S, Ozyurt H Source: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 30 (4): 761-761 JUN 2006 Document Type: Letter Language: English Cited References: 4 Times Cited: 3 4.Title: Massive uvula oedema during lithium therapy and resolution after lithium discontinuation Author(s): Selek S, Herken H, Tutkun H, Savas E, Savas HA, Ozen ME, Virit O, Bayazit Y Source: INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE 10 (1): 73-74 MAR 2006 Document Type: Article Language: English Cited References: 4 Times Cited: 0 5.Title: Jaundice and hepatic enzyme induction during lamotrigine therapy in a bipolar II patient Author(s): Selek S, Savas HA, Savas E, Herken H, Tutkun H, Gergerlioglu HS Source: INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE 9 (1): 65-67 MAR 2005 Document Type: Article Language: English Cited References: 14 Times Cited: 2 6.Title: Frequency of the 17-bp variable number of tandem repeat polymorphism in Turkish schizophrenic patients Author(s): Herken H, Erdal ME, Aynacioglu AS, Barlas O, Cataloluk O, Esgi K, Brockmoller J, Kaiser R Source: SCHIZOPHRENIA RESEARCH 58 (1): 99-100 NOV 1 2002 Document Type: Letter Language: English Cited References: 11 Times Cited: 3 7.Title: Citalopram-induced photopigmentation Author(s): Inaloz HS, Kirtak N, Herken H, Ozgoztasi O, Aynacioglu AS Source: JOURNAL OF DERMATOLOGY 28 (12): 742-745 DEC 2001 Document Type: Article Language: English Cited References: 22 Times Cited: 1 8. Title: Red blood cell nitric oxide levels in patients with schizophrenia Author(s): Herken H, Uz E, Ozyurt H, Akyol O Source: SCHIZOPHRENIA RESEARCH 52 (3): 289-290 DEC 1 2001 Document Type: Letter Language: English Cited References: 9 Times Cited: 22
Uluslararası kongrelerde sunulan, SCI, SCI Expanded, SSCI ve AHCI kapsamındaki dergi özel sayılarında veya aynı kapsamlardaki kongre kitabında veya CD’sinde yayınlanmış sözlü veya poster bildiriler
a.
b.	1.Title: Increased nitric oxide and superoxide dismutase levels in euthymic bipolar patients: Impact of past episodes Author(s): Gergerlioglu HS, Savas HA, Armutcu F, Herken H, Zoroglu SS, Tutkun H, Yilmaz HR, Selek S, Akyol O Source: FASEB JOURNAL 19 (4): A701-A701 Part 1 Suppl. S, MAR 4 2005 Document Type: Meeting Abstract Language: English Cited References: 0 Times Cited: 0 2.Title: Saturation mapping of bipolar affective disorder (BPAD) susceptibility locus on chromosome 20p11.2-q11.2. Author(s): Akarsu AN, Kara-Ozer S, Yuncu Z, Girgin B, Okur H, Sir A, Herken H, Senol S, Radhakrishna U, Blouin JL, Lyle R, Vahip S, Gogus A, Ulusahin A, Antonarakis S Group Author(s): Bipolar Genetics Study Group Source: AMERICAN JOURNAL OF HUMAN GENETICS 71 (4): 469-469 1749 Suppl. S, OCT 2002 Document Type: Meeting Abstract Language: English Cited References: 0 Times Cited: 0 3.Title: 5-HT2A T102C gene polymorphism in Turkish patients with obsessive-compulsive disorder Author(s): Tot S, Erdal ME, Yazici K, Herken H, Yazici A, Buturak V Source: EUROPEAN NEUROPSYCHOPHARMACOLOGY 12: S336-S336 Suppl. 3, OCT 2002 Document Type: Meeting Abstract Language: English Cited References: 0 Times Cited: 0 4.Title: Serotonin transporter gene polymorphism in Turkish patients with obsessive compulsive disorder Author(s): Tot S, Erdal ME, Yazici K, Herken H, Yazici A, Bal N Source: EUROPEAN NEUROPSYCHOPHARMACOLOGY 12: S336-S336 Suppl. 3, OCT 2002 Document Type: Meeting Abstract Language: English Cited References: 0 Times Cited: 0 5.Title: Catechol-O-methyltransferase gene polymorphism in Turkish patients with obsessive-compulsive disorder Author(s): Tot S, Erdal ME, Yazici K, Herken H, Yazici A, Bal N Source: EUROPEAN NEUROPSYCHOPHARMACOLOGY 12: S406-S406 Suppl. 3, OCT 2002 Document Type: Meeting Abstract Language: English Cited References: 0 Times Cited: 0 6.Title: The locus for one form of bipolar affective disorder (BPAD) in a large Turkish family with autosomal dominant inheritance maps on chromosome 20p11-q13. Author(s): Radhakrishna U, Senol S, Herken H, Gucuyener K, Gehrig C, Akarsu AN, Antonarakis SE Source: AMERICAN JOURNAL OF HUMAN GENETICS 65 (4): A32-A32 165 Suppl. S, OCT 1999 Document Type: Meeting Abstract Language: English Cited References: 0 Times Cited: 0
ISI tarafından taranan ve SCI, SCI Expanded, SSCI, AHCI kapsamı dışındaki indekslere(Engineering Index, Compumath Citation Index, Education Index Compendex Inspec, Current Contents, SCOPUS, RePec, ECONLIT, Education Index ,Index Medicus, Physical education index, sport discus ve benzeri uluslararası indeksler) giren dergilerde (uluslararası veya ulusal) yayınlanan
a.
b.
Uluslararası dergilerde yeralan atıflar
a.	Title: Possible association of temporomandibular joint pain and dysfunction with a polymorphism the serotonin transporter gene Author(s): Herken H, Erdal E, Mutlu N, Barlas O, Cataloluk O, Oz F, Guray E Source: AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS 120 (3): 308-313 SEP 2001 Document Type: Article Language: English Cited References: 34 Times Cited: 8 1.Smith BH, Macfarlane GJ, Torrance NEpidemiology of chronic pain, from the laboratory to the bus stop: time to add understanding of biological mechanisms to the study of risk factors in population-based research? PAIN 127 (1-2): 5-10 JAN 2007 2.Valentino B, Melito F, Valentino RAn EMG study of temporo-mandibular joint disorders PAIN CLINIC 14 (3): 287-291 2002 3.Valentino B, Valentino T, Melito FCorrelation between interdental occlusal plane and plantar arches. An EMG study PAIN CLINIC 14 (3): 259-262 2002 4.Valentino B, Aldi B, Melito F, et al.The validity of EMG tests in the diagnosis of the temporo-mandibular joint syndrome PAIN CLINIC 14 (3): 281-285 2002 5.Lotsch J, Skarke C, Liefhold J, et al.Genetic predictors of the clinical response to opioid analgesics – Clinical utility and future perspectives CLINICAL PHARMACOKINETICS 43 (14): 983-1013 2004 6.Diatchenko L, Nackley AG, Slade GD, et al.Idiopathic pain disorders – Pathways of vulnerability PAIN 123 (3): 226-230 AUG 2006. 7.Zoroglu SS, Erdal ME, Alasehirli B, et al.Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder NEUROPSYCHOBIOLOGY 45 (4): 176-181 2002 8.Mutlu N, Erdal ME, Herken H, et al.T102C polymorphism of the 5-HT2A receptor gene may be associated with temporomandibular dysfunction ORAL DISEASES 10 (6): 349-352 NOV 2004 Title: An apparently dominant bipolar affective disorder (BPAD) locus on chromosome 20p11.2-q11.2 in a large Turkish pedigree Author(s): Radhakrishna U, Senol S, Herken H, Gucuyener K, Gehrig C, Blouin JL, Akarsu NA, Antonarakis SE Source: EUROPEAN JOURNAL OF HUMAN GENETICS 9 (1): 39-44 JAN 2001 Document Type: Article Language: English Cited References: 36 Times Cited: 16 1. Detera-Wadleigh SDLithium-related genetics of bipolar disorder ANNALS OF MEDICINE 33 (4): 272-285 MAY 2001 2. Le-Niculescu H, Balaraman Y, Patel S, et al.Towards understanding the schizophrenia code: An expanded convergent functional genomics approach AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 144B (2): 129-158 MAR 5 2007 3. Etain B, Mathieu F, Rietschel M, et al.Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14 MOLECULAR PSYCHIATRY 11 (7): 685-694 JUL 2006 4. Faraone SV, Lasky-Su J, Glatt SJ, et al.Early onset bipolar disorder: possible linkage to chromosome 9q34 BIPOLAR DISORDERS 8 (2): 144-151 APR 2006Arinami T, Arinami T, Ohtsuki T, et al. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p AMERICAN JOURNAL OF HUMAN GENETICS 77 (6): 937-944 DEC 2005 5. McQueen MB, Devlin B, Faraone SV, et al.Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q AMERICAN JOURNAL OF HUMAN GENETICS 77 (4): 582-595 OCT 2005 6. Craddock N, O’Donovan MC, Owen MJThe genetics of schizophrenia and bipolar disorder: dissecting psychosis JOURNAL OF MEDICAL GENETICS 42 (3): 193-204 MAR 2005 7. Ozer S, Ulusahin A, Ulusoy S, et al.Is vitamin D hypothesis for schizophrenia valid? Independent segregation of psychosis in a family with vitamin-D-dependent rickets type IIA PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 28 (2): 255-266 MAR 2004 8. Faraone SV, Glatt SJ, Su J, et al.Three potential susceptibility loci shown by a genome-wide scan for regions influencing the age at onset of mania AMERICAN JOURNAL OF PSYCHIATRY 161 (4): 625-630 APR 2004 9. Tsuang MT, Taylor L, Faraone SVAn overview of the genetics of psychotic mood disorders JOURNAL OF PSYCHIATRIC RESEARCH 38 (1): 3-15 JAN 2004 10. McInnis MG, Dick DM, Willour VL, et al.Genome-wide scan and conditional analysis in bipolar disorder: Evidence for genomic interaction in the National Institute of Mental Health Genetics Initiative bipolar pedigrees BIOLOGICAL PSYCHIATRY 54 (11): 1265-1273 DEC 1 2003 11. Willour VL, Zandi PP, Huo YQ, et al.Genome scan of the fifty-six bipolar pedigrees from the NIMH genetics initiative replication sample: Chromosomes 4, 7, 9, 18, 19, 20, and 21 AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 121B (1): 21-27 AUG 15 2003 12. Segurado R, Detera-Wadleigh SD, Levinson DF, et al.Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder AMERICAN JOURNAL OF HUMAN GENETICS 73 (1): 49-62 JUL 2003 13. McInnis MG, Lan TH, Willour VL, et al.Genome-wide scan of bipolar disorder in 65 pedigrees: supportative evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12 MOLECULAR PSYCHIATRY 8 (3): 288-298 2003 14. üBadner JA, Gershon ESMeta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia MOLECULAR PSYCHIATRY 7 (4): 405-411 2002 17.Baysal BE, Willett-Brozick JE, Badner JA, et al.A mannosyltransferase gene at 11q23 is disrupted by a translocation breakpoint that co-segregates with bipolar affective disorder in a small family NEUROGENETICS 4 (1): 43-53 MAR 2002 Title: Citalopram-induced photopigmentationAuthor(s): Inaloz HS, Kirtak N, Herken H, Ozgoztasi O, Aynacioglu AS Source: JOURNAL OF DERMATOLOGY 28 (12): 742-745 DEC 2001 Document Type: Article Language: English Cited References: 22 Times Cited: 1 1. Aframian DJ. Oral adverse effects for escitalopram (Cipralex((R))) BRITISH JOURNAL OF DERMATOLOGY 156 (5): 1046-1047 MAY 2007 Title: Association of the T102C polymorphism of 5-HT2A receptor gene with aura in migraine Author(s): Erdal ME, Herken H, Yilmaz M, Bayazit YA Source: JOURNAL OF THE NEUROLOGICAL SCIENCES 188 (1-2): 99-101 JUL 15 2001 Document Type: Article Language: English Cited References: 15 Times Cited: 8 1.Colson NJ, Fernandez F, Lea RA, et al.The search for migraine genes: an overview of current knowledge CELLULAR AND MOLECULAR LIFE SCIENCES 64 (3): 331-344 FEB 2007 2. Park JW, Han SR, Yang DW, et al.Serotonin transporter protein polymorphism and harm avoidance personality in migraine without aura HEADACHE 46 (6): 991-996 JUN 2006 3. Yang XS, Xu XP, Yang QD. No association of C-1019G promoter polymorphism of 5-HT1A receptor gene with migraine EUROPEAN JOURNAL OF NEUROLOGY 13 (5): 533-535 MAY 2006 4. Juhasz G, Zsombok T, Laszik A, et al.Association analysis of 5-HTTLPR variants, 5-HT2A receptor gene 102T/C polymorphism and migraine JOURNAL OF NEUROGENETICS 17 (2-3): 231-240 APR-SEP 2003 5. Erdal ME, Herken H, Yilmaz M, et al.Monoamine oxidase-A gene promoter polymorphism in female migraineurs PAIN CLINIC 15 (4): 455-458 2003 6. Tot S, Erdal ME, Yazici K, et al.T102C and-1438 G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive-compulsive disorder EUROPEAN PSYCHIATRY 18 (5): 249-254 AUG 2003 7. Zoroglu SS, Erdal ME, Erdal N, et al.No evidence for an association between the T102C and 1438 G/A polymorphisms of the serotonin 2A receptor gene in attention deficit/hyperactivity disorder in a Turkish population NEUROPSYCHOBIOLOGY 47 (1): 17-20 2003 8. Herken H, Erdal ME, Erdal N, et al.T102C polymorphisms at the 5-HT2A receptor gene in Turkish schizophrenia patients: A possible association with prognosis NEUROPSYCHOBIOLOGY 47 (1): 27-30 2003 Title: Serum IL-1 beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment Author(s): Erbagci AB, Herken H, Koyluoglu O, Yilmaz N, Tarakcioglu M Source: MEDIATORS OF INFLAMMATION 10 (3): 109-115 JUN 2001 Document Type: Article Language: English Cited References: 32 Times Cited: 19 1. Shirts BH, Wood J, Yolken RH, et al. Association study of IL10, IL1 beta, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: Suggestive association with rs 16944 at IL1 beta SCHIZOPHRENIA RESEARCH 88 (1-3): 235-244 DEC 2006 2. Drzyzga L, Obuchowicz E, Marcinowska A, et al.Cytokines in schizophrenia and the effects of antipsychotic drugs BRAIN BEHAVIOR AND IMMUNITY 20 (6): 532-545 NOV 2006 3. Strous RD, Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: A comprehensive model updated and revisited JOURNAL OF AUTOIMMUNITY 27 (2): 71-80 SEP 2006 4. Pae CU, Serretti A, Artioli P, et al.Interaction analysis between 5-HTTLPR and TNFA-238/-308 polymorphisms in schizophreniaJOURNAL OF NEURAL TRANSMISSION 113 (7): 887-897 JUL 2006 5. Vogel M, Busse S, Freyberger HJ, et al.Dopamine D3 receptor and schizophrenia: A widened scope for the immune hypothesis MEDICAL HYPOTHESES 67 (2): 354-358 2006 6. Yang YF, Wan CL, Li HF, et al.Altered levels of acute phase proteins in the plasma of patients with schizophrenia ANALYTICAL CHEMISTRY 78 (11): 3571-3576 JUN 1 2006 7. Justo DSmoldering systemic inflammation: a link between schizophrenia, smoking and obesity ACTA PSYCHIATRICA SCANDINAVICA 113 (4): 245-246 APR 2006 8. Pae CU, Yoon CH, Kim TS, et al.Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines INTERNATIONAL IMMUNOPHARMACOLOGY 6 (4): 666-671 APR 2006 9. Hanson DR, Gottesman IITheories of schizophrenia: a genetic-inflammatory-vascular synthesis BMC MEDICAL GENETICS 6: Art. No. 7 FEB 11 2005 10. Saviouk V, Chow EWC, Bassett AS, et al.Tumor necrosis factor promoter haplotype associated with schizophrenia reveals a linked locus on 1q44 MOLECULAR PSYCHIATRY 10 (4): 375-383 APR 2005 11.Androsova LV, Sekirina TP, Kushner SG, et al.Interleukine system in schizophrenics ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA 104 (2): 43-47 2004 12. Schuld A, Hinze-Selch D, Pollmacher TCytokine networks in patients with schizophrenia and their possible role in its pathophysiology NERVENARZT 75 (3): 215-226 MAR 2004 13. Hashimoto R, Yoshida M, Ozaki N, et al.Association analysis of the -308G > A promoter polymorphism of the tumor necrosis factor alpha (TNF-alpha) gene in Japanese patients with schizophrenia JOURNAL OF NEURAL TRANSMISSION 111 (2): 217-221 FEB 2004 14. Tsai SJ, Hong CJ, Yu YWY, et al.No association of tumor necrosis factor alpha gene polymorphisms with schizophrenia or response to clozapine SCHIZOPHRENIA RESEARCH 65 (1): 27-32 DEC 1 2003 15. Tan EC, Chong SA, Tan CH, et al.Tumor necrosis factor-alpha gene promoter polymorphisms in chronic schizophrenia BIOLOGICAL PSYCHIATRY 54 (11): 1205-1211 DEC 1 2003 16. Sutherland AG, Alexander DA, Hutchison JD.Disturbance of pro-inflammatory cytokines in post-traumatic psychopathology CYTOKINE 24 (5): 219-225 DEC 7 2003 17. Handoko HY, Nancarrow DJ, Hayward NK, et al.Tumor necrosis factor haplotype analysis amongst schizophrenia probands from four distinct populations in the Asia-Pacific region.AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 121B (1): 1-6 AUG 15 2003 18. Pae CU, Chae JH, Bahk WM, et al.Tumor necrosis factor-alpha gene polymorphism at position -308 and schizophrenia in the Korean population PSYCHIATRY AND CLINICAL NEUROSCIENCES 57 (4): 399-403 AUG 2003 19. Breunis MN, Kupka RW, Nolen WA, et al.High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder BIOLOGICAL PSYCHIATRY 53 (2): 157-165 JAN 15 2003 Title: Significance of the catechol-O-methyltransferase gene polymorphism in migraine Author(s): Erdal ME, Herken H, Yilmaz M, Bayazit YA Source: MOLECULAR BRAIN RESEARCH 94 (1-2): 193-196 OCT 19 2001 Document Type: Article Language: English Cited References: 13 Times Cited: 3 1.Hagen K, Pettersen E, Stovner LJ, et al.No association between chronic musculoskeletal complaints and Val158Met polymorphism in the Catechol-O-methyltransferase gene. The HUNT study BMC MUSCULOSKELETAL DISORDERS 7: Art. No. 40 MAY 4 2006 2.Erdal ME, Herken H, Yilmaz M, et al.Monoamine oxidase-A gene promoter polymorphism in female migraineurs PAIN CLINIC 15 (4): 455-458 2003 3.Gursoy S, Erdal E, Herken H, et al.Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome RHEUMATOLOGY INTERNATIONAL 23 (3): 104-107 MAY 2003 Title: Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis Author(s): Herken H, Erdal ME Source: PSYCHIATRIC GENETICS 11 (2): 105-109 JUN 2001 Document Type: Article Language: English Cited References: 19 Times Cited: 29 1. Demiralp T, Herrmann CS, Erdal ME, et al.DRD4 and DAT1 polymorphisms modulate human gamma band responses CEREBRAL CORTEX 17 (5): 1007-1019 MAY 2007 2. Carandang CG, Scholten MCMetyrosine in psychosis associated with 22q11.2 deletion syndrome: Case report JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY 17 (1): 115-120 FEB 2007 3. Golimbet VE, Aflimova MV, Gritsenko IK, et al.Dopamine system genes and personality traits of extraversion and novelty seeking ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA 56 (4): 457-463 JUL-AUG 2006 4. Rybakowski JK, Borkowska A, Czerski PM, et al.Performance on the Wisconsin Card Sorting Test in schizophrenia and genes of dopaminergic inactivation (COMT, DAT, NET) PSYCHIATRY RESEARCH 143 (1): 13-19 JUN 30 2006 5. Glaser B, Debbane M, Hinard C, et al.No evidence for an effect of COMT Val158Met genotype on executive function in patients with 22q11 deletion syndrome AMERICAN JOURNAL OF PSYCHIATRY 163 (3): 537-539 MAR 2006 6. Han DH, Kee BS, Min KJ, et al.Effects of catechol-O-methyltransferase VaII58Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients NEUROREPORT 17 (1): 95-99 JAN 23 2006 7. Joo EJ, Jeong SH, Ahn YM, et al.No association found between 158 Val/Met polymorphism of the COMT gene and schizophrenia with minor physical anomalies PSYCHIATRY RESEARCH 136 (2-3): 83-91 SEP 15 2005 8. Munafo MR, Bowes L, Clark TG, et al.Lack of association of the COMT (Val(158/108) Met) gene and schizophrenia: A meta-analysis of case-control studies MOLECULAR PSYCHIATRY 10 (8): 765-770 AUG 2005 9. Volavka J, Bilder R, Nolan KCatecholamines and aggression – The role of COMT and MAO polymorphismsANNALS OF THE NEW YORK ACADEMY OF SCIENCES 1036: 393-398 2004 10. Ftouh S, Akbar MT, Hirsch SR, et al.Down-regulation of Dickkopf 3, a regulator of the Wnt signalling pathway, in elderly schizophrenic subjects JOURNAL OF NEUROCHEMISTRY 94 (2): 520-530 JUL 2005 11. Ho BC, Wassink TH, O’Leary DS, et al.Catechol-O-methyl transferase Val(158)Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flowMOLECULAR PSYCHIATRY 10 (3): 287-298 MAR 2005 12. Fan JB, Zhang CS, Gu NF, et al.Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: A large-scale association study plus meta-analysis BIOLOGICAL PSYCHIATRY 57 (2): 139-144 JAN 15 2005 13. Sazci A, Ergul E, Kucukali I, et al.Catechol-O-methyltransferase gene Val 108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women MOLECULAR BRAIN RESEARCH 132 (1): 51-56 DEC 6 2004 14. Bilder RM, Volavka J, Lachman HM, et al.The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes NEUROPSYCHOPHARMACOLOGY 29 (11): 1943-1961 NOV 2004 15. Hennah W, Varilo T, Paunio T, et al.Haplotype analysis and identification of genes for a complex trait: examples from schizophrenia ANNALS OF MEDICINE 36 (5): 322-331 2004 16. Goldman-Rakic PS, Castner SA, Svensson TH, et al.Targeting the dopamine D-1 receptor in schizophrenia: insights for cognitive dysfunction PSYCHOPHARMACOLOGY 174 (1): 3-16 JUN 2004 17. Volavka A, Bilder RM, Lachman HMGenetic linkage for schizophrenia? AMERICAN JOURNAL OF PSYCHIATRY 161 (6): 1134-1135 JUN 2004 18. Tsai SJ, Hong CJ, Liao DL, et al.Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia NEUROPSYCHOBIOLOGY 49 (4): 196-200 2004 19. Elkin A, Kalidindi S, McGuffin PHave schizophrenia genes been found? CURRENT OPINION IN PSYCHIATRY 17 (2): 107-113 MAR 2004 20. Berry N, Jobanputra V, Pal HMolecular genetics of schizophrenia: a critical reviewJOURNAL OF PSYCHIATRY & NEUROSCIENCE 28 (6): 415-429 NOV 2003 21. Illi A, Mattila KM, Kampman O, et al.Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 23 (5): 429-434 OCT 2003 22. Winterer G, Weinberger DRCortical signal-to-noise ratio: insight into the pathophysiology and genetics of schizophrenia CLINICAL NEUROSCIENCE RESEARCH 3 (1-2): 55-66 MAY 2003 23. Gallinat J, Bajbouj M, Sander T, et al.Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing BIOLOGICAL PSYCHIATRY 54 (1): 40-48 JUL 1 2003 24. Inada T, Nakamura A, Iijima Y.Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 120B (1): 35-39 JUL 1 2003 25. Wonodi I, Stine OC, Mitchell BD, et al.Association between Val(108/158) met polymorphism of the COMT gene and schizophrenia.AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 120B (1): 47-50 JUL 1 2003 26. Quintana J, Wong T, Ortiz-Portillo E, et al.Right lateral fusiform gyrus dysfunction during facial information processing in schizophrenia BIOLOGICAL PSYCHIATRY 53 (12): 1099-1112 JUN 15 2003 27. Glatt SJ, Faraone SV, Tsuang MT.Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: Meta-analysis of case-control and family-based studies AMERICAN JOURNAL OF PSYCHIATRY 160 (3): 469-476 MAR 2003 28. Levinson DFMolecular genetics of schizophrenia: a review of the recent literature CURRENT OPINION IN PSYCHIATRY 16 (2): 157-170 MAR 2003 29. Tsai SJ, Yu YWY, Chen TJ, et al.Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females EUROSCIENCE LETTERS 338 (2): 123-126 FEB 27 2003 Title: Association of T102C polymorphism of the 5-HT2A receptor gene with pyschiatric status in fibromyalgia syndrome Author(s): Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B Source: RHEUMATOLOGY INTERNATIONAL 21 (2): 58-61 OCT 2001 Document Type: Article Language: English Cited References: 12 Times Cited: 12 1. McBeth J, Silman AJ, Gupta A, et al.Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain – Findings of a population-based prospective cohort study ARTHRITIS AND RHEUMATISM 56 (1): 360-371 JAN 2007 2. Su SY, Chen JJH, Lai CC, et al.The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4 CLINICAL RHEUMATOLOGY 26 (1): 12-16 JAN 2007 3. Bazzichi L, Giannaccini G, Betti L, et al. Alteration of serotonin transporter density and activity in fibromyalgia ARTHRITIS RESEARCH & THERAPY 8 (4): Art. No. R99 2006 4.Bennett RM Three years later: Presidential address to MYOPAIN ’04JOURNAL OF MUSCULOSKELETAL PAIN 12 (3-4): 1-12 2004 5.Zarros AC, Kalopita KS, Tsakiris STSerotoninergic impairment and aggressive behavior in Alzheimer’s disease ACTA NEUROBIOLOGIAE EXPERIMENTALIS 65 (3): 277-286 2005 6. Mutlu N, Erdal ME, Herken H, et al.T102C polymorphism of the 5-HT2A receptor gene may be associated with temporomandibular dysfunction ORAL DISEASES 10 (6): 349-352 NOV 2004 7. Goldenberg DL, Burckhardt C, Crofford L.Management of fibromyalgia syndrome JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 292 (19): 2388-2395 NOV 17 2004 8. Lam LCW, Tang NLS, Ma SL, et al. 5-HT(2A)T102C receptor polymorphism and neuropsychiatric symptoms in Alzheimer’s disease INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY 19 (6): 523-526 JUN 2004 9. Arnold LM, Hudson JI, Hess EV, et al.Family study of fibromyalgia. ARTHRITIS AND RHEUMATISM 50 (3): 944-952 MAR 2004 10. Rubinow A.Fibromyalgia: A distinct entity? ISRAEL MEDICAL ASSOCIATION JOURNAL 5 (12): 885-886 DEC 2003 11. Gursoy S, Erdal E, Herken H, et al.Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. RHEUMATOLOGY INTERNATIONAL 23 (3): 104-107 MAY 2003 12. Herken H, Erdal ME, Erdal N, et al. T102C polymorphisms at the 5-HT2A receptor gene in Turkish schizophrenia patients: A possible association with prognosis NEUROPSYCHOBIOLOGY 47 (1): 27-30 2003 Title: Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation ape increased in different forms of schizophrenia. Author(s): Herken H, Uz E, Ozyurt H, Sogut S, Virit O, Akyol O Source: MOLECULAR PSYCHIATRY 6 (1): 66-73 JAN 2001 Document Type: Article Language: English Cited References: 54 Times Cited: 57 1. Grignon S, Chianetta JM.Assessment of malondialdehyde levels in schizophrenia: A meta-analysis and some methodological considerations PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 31 (2): 365-369 MAR 30 2007 2. Herken H, Gurel A, Selek S, et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: Impact of antidepressant treatment ARCHIVES OF MEDICAL RESEARCH 38 (2): 247-252 FEB 2007 3. Ozyurt B, Sarsilmaz M, Akpolat N, et al. The protective effects of omega-3 fatty acids against MK-801-induced neurotoxicity in prefrontal cortex of rat NEUROCHEMISTRY INTERNATIONAL 50 (1): 196-202 JAN 2007 4. Tosic M, Ott J, Barral S, et al.Schizophrenia and oxidative stress: Glutamate cysteine ligase modifier as a susceptibility gene AMERICAN JOURNAL OF HUMAN GENETICS 79 (3): 586-592 SEP 2006 5. Ustundag B, Atmaca M, Kirtas O, et al.Total antioxidant response in patients with schizophrenia PSYCHIATRY AND CLINICAL NEUROSCIENCES 60 (4): 458-464 AUG 2006 6. Cabungcal JH, Nicolas D, Kraftsik R, et al.Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: Relevance to schizophrenia. NEUROBIOLOGY OF DISEASE 22 (3): 624-637 JUN 2006 7. Berger GE, Smesny S, Amminger GP. Bioactive lipids in schizophrenia. INTERNATIONAL REVIEW OF PSYCHIATRY 18 (2): 85-98 APR 2006 8. Mahadik SP, Pillai A, Joshi S, et al.Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia INTERNATIONAL REVIEW OF PSYCHIATRY 18 (2): 119-131 APR 2006 9. Fendri C, Mechri A, Khiari G, et al.Oxidative stress involvement in schizophrenia pathophysiology : a review ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE 32 (2): 244-252 Part 1 MAR-APR 2006 10. Gama CS, Salvador M, Andreazza AC, et al. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: A study of patients treated with haloperidol or clozapine PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 30 (3): 512-515 MAY 2006 11. Savas HA, Gergerlioglu HS, Armutcu F, et al.Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: Impact of past episodes WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY 7 (1): 51-55 2006 12. Zhang XY, Tan YL, Cao LY, et al. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics SCHIZOPHRENIA RESEARCH 81 (2-3): 291-300 JAN 31 2006 13. Steullet P, Neijt HC, Cuenod M, et al.Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia NEUROSCIENCE 137 (3): 807-819 2006 14. Herken H, Akyol O, Yilmaz HR, et al.Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL 21 (1): 53-59 JAN 2006 15. Atmaca M, Tezcan E, Kuloglu M, et al.The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia PSYCHIATRY AND CLINICAL NEUROSCIENCES 59 (6): 652-656 DEC 2005 16. Ozturk E, Demirbilek S, But AK, et al.Antioxidant properties of propofol and erythropoietin after closed head injury in rats PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 29 (6): 920-925 JUL 2005 17. Iraz M, Erdogan H, Ozyurt B, et al.Omega-3 essential fatty acid supplementation and erythrocyte oxidant/antioxidant status in rats ANNALS OF CLINICAL AND LABORATORY SCIENCE 35 (2): 169-173 SPR 2005 18. Yao JK, Thomas EA, Reddy RD, et al.Association of plasma apolipoproteins D with RBC membrane arachidonic acid levels in schizophrenia SCHIZOPHRENIA RESEARCH 72 (2-3): 259-266 JAN 1 2005 19. Akyol O, Yanik M, Elyas H, et al.Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 29 (1): 123-131 JAN 2005 Times Cited: 6 20. Chauhan A, Chauhan V, Brown WT, et al.Oxidative stress in autism: Increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin – the antioxidant proteins LIFE SCIENCES 75 (21): 2539-2549 OCT 8 2004 21. Khalifa AE Pro-oxidant activity of zuclopenthixol in vivo: differential effect of the drug on brain oxidative status of scopolamine-treated rats HUMAN & EXPERIMENTAL TOXICOLOGY 23 (9): 439-445 SEP 2004 22. Michel TM, Thome J, Martin D, et al.Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis JOURNAL OF NEURAL TRANSMISSION 111 (9): 1191-1201 SEP 2004 23. Songur A, Sarsilmaz M, Sogut S, et al.Hypothalamic superoxide dismutase, xanthine oxidase, nitric oxide, and malondialdehyde in rats fed with fish omega-3 fatty acids PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 28 (4): 693-698 JUL 2004 24. Atmaca M, Tezcan E, Kuloglu M, et al.Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 254 (4): 231-235 AUG 2004 25. Akyol O, Zoroglu SS, Armutcu F, et al.Nitric oxide as a physiopathological factor in neuropsychiatric disorders IN VIVO 18 (3): 377-390 MAY-JUN 2004 26. Zoroglu SS, Armutcu F, Ozen S, et al.Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 254 (3): 143-147 JUN 2004 27. Akyol O, Canatan H, Yilmaz HR, et al.PCR/RFLP-based cost-effective identification of SOD2 signal (leader) sequence polymorphism (Ala-9Val) using NgoM IV: a detailed methodological approach CLINICA CHIMICA ACTA 345 (1-2): 151-159 JUL 2004 28. Dakhale G, Khanzode S, Khanzode S, et al.Oxidative damage and schizophrenia: The potential benefit by atypical antipsychotics NEUROPSYCHOBIOLOGY 49 (4): 205-209 2004 29. Wang JF, Shao L, Sun XJ, et al.Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons JOURNAL OF NEUROCHEMISTRY 88 (6): 1477-1484 MAR 2004 30. Castagne V, Cuenod M, Do KQ An animal model with relevance to schizophrenia: Sex-dependent cognitive deficits in osteogenic disorder-Shionogi rats induced by glutathione synthesis and dopamine uptake inhibition during development NEUROSCIENCE 123 (4): 821-834 2004 31. Castagne V, Rougemont M, Cuenod M, et al.Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat’s development induce long-term cognitive deficit: relevance to schizophrenia NEUROBIOLOGY OF DISEASE 15 (1): 93-105 FEB 2004 32. Khanzode SD, Dakhale GN, Khanzode SS, et al.Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors REDOX REPORT 8 (6): 365-370 2003 33. Ponizovsky AM, Barshtein G, Bergelson LD Biochemical alterations of erythrocytes as an indicator of mental disorders: An overview HARVARD REVIEW OF PSYCHIATRY 11 (6): 317-332 NOV-DEC 2003 34. Li HL, Liu DP, Liang CC Paraoxonase gene polymorphisms, oxidative stress, and diseases JOURNAL OF MOLECULAR MEDICINE-JMM 81 (12): 766-779 DEC 2003 35. Sarsimaz M, Songur A, Kus I, et al.The regulatory role of dietary omega-3 essential fatty acids on oxidant/antioxidant balance in rat hippocampus NEUROSCIENCE RESEARCH COMMUNICATIONS 33 (2): 114-123 SEP-OCT 2003 36. Fadillioglu E, Erdogan H, Iraz M, et al.Effects of caffeic acid phenethyl ester against doxorubicin-induced neuronal oxidant injury NEUROSCIENCE RESEARCH COMMUNICATIONS 33 (2): 132-138 SEP-OCT 2003 37. Sarsilmaz M, Songur A, Ozyurt H, et al.Potential role of dietary omega-3 essential fatty acids on some oxidant/antioxidant parameters in rats’ corpus striatum PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS 69 (4): 253-259 OCT 2003 38. Thomas EA, Copolov DL, Sutcliffe JG From pharmacotherapy to pathophysiology: Emerging mechanisms of apolipoprotein D in psychiatric disorders CURRENT MOLECULAR MEDICINE 3 (5): 408-418 AUG 2003 39. Tezcan E, Atmaca M, Kuloglu M, et al.Free radicals in patients with post-traumatic stress disorder EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 253 (2): 89-91 APR 2003 40. Hori H, Ohmori O, Matsumoto C, et al.NAD(P)H: quinone oxidoreductase (NQO1) gene polymorphism and schizophrenia PSYCHIATRY RESEARCH 118 (3): 235-239 JUN 15 2003 41. Erkilic K, Evereklioglu C, Cekmen M, et al.Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behcet’s disease: original contributions/clinical and laboratory investigations MEDIATORS OF INFLAMMATION 12 (2): 107-116 APR 2003 42. Hasan HA, Erdal ME, Boke O, et al.Tardive dyskinesia is not associated with the polymorphisms of 5-HT2A receptor gene, serotonin transporter gene and catechol-o-methyltransferase gene EUROPEAN PSYCHIATRY 18 (2): 77-81 MAR 2003 43. Rao ML, Kolsch H Effects of estrogen on brain development and neuroprotection-implications for negative symptoms in schizophrenia PSYCHONEUROENDOCRINOLOGY 28: 83-96 Suppl. 2 APR 2003 44. Ozerol E, Aslan M, Cakmak EA, et al.The effect of long-term therapy with sodium valproate on oxidant/antioxidant status in epileptic children NEUROSCIENCE RESEARCH COMMUNICATIONS 32 (2): 115-122 MAR-APR 2003 45. Sogut S, Zoroglu SS, Ozyurt H, et al.Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism CLINICA CHIMICA ACTA 331 (1-2): 111-117 MAY 2003 46. Zhang XY, Zhou DF, Cao LY, et al.The effect of risperidone treatment on superoxide dismutase in schizophrenia JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 23 (2): 128-131 APR 2003 47. Kuloglu M, Atmaca M, Tezcan E, et al.Antioxidant enzyme and malondialdehyde levels in patients with panic disorder NEUROPSYCHOBIOLOGY 46 (4): 186-189 2002 48. Zoroglu SS, Yurekli M, Meram I, et al.Pathophysiological role of nitric oxide and adrenomedullin in autism CELL BIOCHEMISTRY AND FUNCTION 21 (1): 55-60 MAR 2003 49. Wang JF, Azzam JE, Young LT Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells NEUROSCIENCE 116 (2): 485-489 2003 50. Fadillioglu E, Erdogan H, Sogut S, et al.Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats JOURNAL OF APPLIED TOXICOLOGY 23 (1): 71-74 JAN-FEB 2003 51. Mahadik SP, Khan MM, Evans DR, et al.Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome SCHIZOPHRENIA RESEARCH 58 (1): 55-62 NOV 1 2002 52. Zoroglu SS, Herken H, Yurekli M, et al.The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia JOURNAL OF PSYCHIATRIC RESEARCH 36 (5): 309-315 SEP-OCT 2002 53. Akyol O, Herken H, Uz E, et al.The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients The possible role of oxidant/antioxidant imbalance PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 26 (5): 995-1005 JUN 2002 54. Kuloglu M, Atmaca M, Tezcan E, et al.Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder NEUROPSYCHOBIOLOGY 46 (1): 27-32 2002 55. Matsumoto C, Ohmori O, Hori H, et al.Analysis of association between the Gln192Arg polymorphism of the paraoxonase gene and schizophrenia in humans NEUROSCIENCE LETTERS 321 (3): 165-168 MAR 22 2002 56. Karlidag T, Yalcin S, Ozturk A, et al.The role of free oxygen radicals in noise induced hearing loss: effects of melatonin and methylprednisolone AURIS NASUS LARYNX 29 (2): 147-152 JAN 2002 57. Kaygusuz I, Ozturk A, Ustundag B, et al.Role of free oxygen radicals in noise-related hearing impairment HEARING RESEARCH 162 (1-2): 43-47 DEC 2001 Title: Significance of serotonin transporter gene polymorphism in migraine Author(s): Yilmaz M, Erdal ME, Herken H, Cataloluk O, Barlas O, Bayazit YA Source: JOURNAL OF THE NEUROLOGICAL SCIENCES 186 (1-2): 27-30 MAY 1 2001 Document Type: Article Language: English Cited References: 14 Times Cited: 23 1.Nagata E, Hamada J, Shimizu T, et al.Altered levels of serotonin in lymphoblasts derived from migraine patients NEUROSCIENCE RESEARCH 57 (2): 179-183 FEB 2007 2. Colson NJ, Fernandez F, Lea RA, et al.The search for migraine genes: an overview of current knowledge CELLULAR AND MOLECULAR LIFE SCIENCES 64 (3): 331-344 FEB 2007 3. Erdal N, Herken H, Yilmaz M, et al.The A218C polymorphism of tryptophan hydroxylase gene and migraine JOURNAL OF CLINICAL NEUROSCIENCE 14 (3): 249-251 MAR 2007 4. Todt U, Freudenberg J, Goebel I, et al.Variation of the serotonin transporter gene SLC6A4 in the susceptibility to migraine with aura NEUROLOGY 67 (9): 1707-1709 NOV 14 2006 5. De Vries B, Haan J, Frants RR, et al.Genetic biomarkers for migraine HEADACHE 46 (7): 1059-1068 JUL-AUG 2000 6. Loder E, Harrington MG, Cutrer M, et al.Selected confirmed, probable, and exploratory migraine biomarkers HEADACHE 46 (7): 1108-1127 JUL-AUG 2006 7. Park JW, Han SR, Yang DW, et al.Serotonin transporter protein polymorphism and harm avoidance personality in migraine without aura HEADACHE 46 (6): 991-996 JUN 2006 8. Szilagyi A, Boor K, Orosz I, et al.Contribution of serotonin transporter gene polymorphisms to pediatric migraine HEADACHE 46 (3): 478-485 MAR 2006 9.Bayazit YA, Yilmaz M, Ciftci T, et al.Association of the-1438G/A polymorphism of the 5-HT2A receptor gene with obstructive sleep apnea syndrome ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES 68 (3): 123-128 2006 10. Nyholt DR, Morley KI, Ferreira MAR, et al.Genomewide significant linkage to migrainous headache on chromosome 5q21 AMERICAN JOURNAL OF HUMAN GENETICS 77 (3): 500-512 SEP 2005 11. Kim WK, Kim HS, Kim WJ, et al.Serotonin transporter gene polymorphism and migraine in the Korean population HEADACHE 45 (8): 1056-1060 SEP 2005 12. Yilmaz M, Bayazit YA, Ciftci TU, et al.Association of serotonin transporter gene polymorphism with obstructive sleep apnea syndrome LARYNGOSCOPE 115 (5): 832-836 MAY 2005 13. Marziniak M, Mossner R, Schmitt A, et al.A functional serotonin transporter gene polymorphism is associated with migraine with aura NEUROLOGY 64 (1): 157-159 JAN 11 2005 14. Estevez M, Gardner KL Update on the genetics of migraine HUMAN GENETICS 114 (3): 225-235 FEB 2004 15. Juhasz G, Zsombok T, Laszik A, et al.Association analysis of 5-HTTLPR variants, 5-HT2A receptor gene 102T/C polymorphism and migraine JOURNAL OF NEUROGENETICS 17 (2-3): 231-240 APR-SEP 2003 16.Cakmak EA, Cataloluk O, Yoldas T, et al.Migraine and angiotensin-converting enzyme association in Turkish patients PAIN CLINIC 15 (4): 473-477 2003 17.Erdal ME, Yilmaz M, Herken H, et al.The 1438G/A polymorphism of the 5-HT2A receptor gene is associated with aura in migraine PAIN CLINIC 15 (3): 315-319 2003 18.Juhasz G, Zsombok T, Laszik A, et al.Despite the general correlation of the serotonin transporter gene regulatory region polymorphism (5-HTTLPR) and platelet serotonin concentration, lower platelet serotonin concentration in migraine patients is independent of the 5-HTTLPR variants NEUROSCIENCE LETTERS 350 (1): 56-60 OCT 16 2003 19.Hasan HA, Erdal ME, Boke O, et al.Tardive dyskinesia is not associated with the polymorphisms of 5-HT2A receptor gene, serotonin transporter gene and catechol-o-methyltransferase gene EUROPEAN PSYCHIATRY 18 (2): 77-81 MAR 2003 20.Cassidy EM, Tomkins E, Sharifi N, et al.Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone PAIN 101 (3): 283-290 FEB 2003 21.Ducros A, Tournier-Lasserve E, Bousser MG The genetics of migraine LANCET NEUROLOGY 1 (5): 285-293 SEP 2002 22.Zoroglu SS, Erdal ME, Alasehirli B, et al.Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder NEUROPSYCHOBIOLOGY 45 (4): 176-181 2002 23. Bethea CL, Lu NZ, Gundlah C, et al.Diverse actions of ovarian steroids in the serotonin neural system FRONTIERS IN NEUROENDOCRINOLOGY 23 (1): 41-100 JAN 2002 Title: Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia Author(s): Yanik M, Kocyigit A, Tutkun H, Vural H, Herken H Source: BIOLOGICAL TRACE ELEMENT RESEARCH 98 (2): 109-117 MAY 2004 Document Type: Article Language: English Cited References: 37 Times Cited: 2 1.Mocchegiani E, Bertoni-Freddari C, Marcellini F, et al.Brain, aging and neurodegeneration: Role of zinc ion availability PROGRESS IN NEUROBIOLOGY 75 (6): 367-390 APR 2005 2. Wolf TL, Kotun J, Meador-Woodruff JH Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia SCHIZOPHRENIA RESEARCH 86 (1-3): 167-171 SEP 2006 Title: Pathophysiological role of nitric oxide and adrenomedullin in autism Author(s): Zoroglu SS, Yurekli M, Meram I, Sogut S, Tutkun H, Yetkin O, Sivasli E, Savas HA, Yanik M, Herken H, Akyol O Source: CELL BIOCHEMISTRY AND FUNCTION 21 (1): 55-60 MAR 2003 Document Type: Article Language: English Cited References: 43 Times Cited: 9 1. Ming X, Stein TP, Brimacombe M, et al.Increased excretion of a lipid peroxidation biomarker in autism PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS 73 (5): 379-384 NOV 2005 2. Taneli F, Pirildar S, Akdeniz F, et al.Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia ARCHIVES OF MEDICAL RESEARCH 35 (5): 401-405 SEP-OCT 2004 3. McGinnis WR Oxidative stress in autism ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE 10 (6): 22-36 NOV-DEC 2004 4. Huang CH, Chen ML, Tsai YL, et al.Elevated adrenomedullin mRNA in lymphoblastoid cells from schizophrenic patients NEUROREPORT 15 (9): 1443-1446 JUN 28 2004 5. Manto MU, Fatemi H Nitric oxide in the cerebellum of mutant mice CEREBELLUM 3 (3): 130-132 2004 6. Akyol O, Zoroglu SS, Armutcu F, et al.Nitric oxide as a physiopathological factor in neuropsychiatric disorders IN VIVO 18 (3): 377-390 MAY-JUN 2004 7. Sweeten TL, Posey DJ, Shankar S, et al.High nitric oxide production in autistic disorder: A possible role for interferon-gamma BIOLOGICAL PSYCHIATRY 55 (4): 434-437 FEB 15 2004 8. Yilmaz N, Herken H, Cicek HK, et al.Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia MEDICAL PRINCIPLES AND PRACTICE 16 (2): 137-141 2007 9. Savas HA, Gergerlioglu HS, Armutcu F, et al.Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: Impact of past episodes WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY 7 (1): 51-55 2006 Title: Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive-compulsive disorder Author(s): Erdal ME, Tot S, Yazici K, Yazici A, Herken H, Erdem P, Derici E, Camdeviren H Source: DEPRESSION AND ANXIETY 18 (1): 41-45 2003 Document Type: Article Language: English Cited References: 34 Times Cited: 7 1. Hill RA, McInnes KJ, Gong ECH, et al.Estrogen deficient male mice develop compulsive behavior BIOLOGICAL PSYCHIATRY 61 (3): 359-366 FEB 1 2007 Kim SJ, Kim CH The genetic studies of obsessive-compulsive disorder and its future directions YONSEI MEDICAL JOURNAL 47 (4): 443-454 AUG 31 2006 2. Denys D, Van Nieuwerburgh F, Deforce D, et al.Association between the dopamine D-2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males EUROPEAN NEUROPSYCHOPHARMACOLOGY 16 (6): 446-450 AUG 2006 3. Mundo E, Zanoni S, Altamura AC Genetic issues in obsessive-compulsive disorder and related disorders PSYCHIATRIC ANNALS 36 (7): 494+ JUL 2006 Hemmings SMJ, Stein DJ The current status of association studies in obsessive-compulsive disorder PSYCHIATRIC CLINICS OF NORTH AMERICA 29 (2): 411+ JUN 2006 Times Cited: 2 4. Denys D, Zohar J, Westenberg HGM The role of dopamine in obsessive-compulsive disorder: Preclinical and clinical evidence JOURNAL OF CLINICAL PSYCHIATRY 65: 11-17 Suppl. 14 2004 5. Denys D, Klompmakers AA, Westenberg HGM Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine PSYCHOPHARMACOLOGY 176 (2): 195-203 NOV 2004 Title: The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder Author(s): Yanik M, Vural H, Tutkun H, Zoroglu SS, Sava HA, Herken H, Kocyigit A, Keles H, Akyol O Source: EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 254 (1): 43-47 FEB 2004 Document Type: Article Language: English Cited References: 40 Times Cited: 4 1. Hoekstra R, Fekkes D, Pepplinkhuizen L, et al.Nitric oxide and neopterin in bipolar affective disorder NEUROPSYCHOBIOLOGY 54 (1): 75-81 2006 Reif A, Strobel A, Jacob CP, et al. A NOS-III haplotype that includes functional polymorphisms is associated with bipolar disorder INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 9 (1): 13-20 FEB 2006 2. Bernstein HG, Bogerts B, Keilhoff G The many faces of nitric oxide in schizophrenia. A review SCHIZOPHRENIA RESEARCH 78 (1): 69-86 OCT 1 2005 3. Adan A, Prat G Functions and therapeutic potential of nitric oxide in Central Nervous System PSICOTHEMA 17 (2): 275-280 MAY 2005 Title: Alexithymic features in migraine patients Author(s): Muftuoglu MN, Herken H, Demirci H, Virit O, Neyal A Source: EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 254 (3): 182-186 JUN 2004 Document Type: Article Language: English Cited References: 28 Times Cited: 1 1.Abbate-Daga G, Fassino S, Lo Giudice R, et al.Anger, depression and personality dimensions in patients with migraine without aura PSYCHOTHERAPY AND PSYCHOSOMATICS 76 (2): 122-128 2007 1. Title: Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment Author(s): Herken H, Akyol O, Yilmaz HR, Tutkun H, Savas HA, Ozen ME, Kalenderoglu A, Gulec M Source: HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL 21 (1): 53-59 JAN 2006 Document Type: Article Language: English Cited References: 39 Times Cited: 3 1. Pae CU, Yoon SJ, Patkar A, et al.Manganese superoxide dismutase (MnSOD : Ala-9Val) gene polymorphism and mood-disorders: A preliminary study PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 30 (7): 1326-1329 SEP 30 2006 2. Herken H, Gurel A, Selek S, et al.Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: Impact of antidepressant treatment ARCHIVES OF MEDICAL RESEARCH 38 (2): 247-252 FEB 2007 3. Brunstein MG, Silveira EM, Chaves LS, et al.Increased serum adenosine deaminase activity in schizophrenic receiving antipsychotic treatment NEUROSCIENCE LETTERS 414 (1): 61-64 FEB 27 2007 Title: Jaundice and hepatic enzyme induction during lamotrigine therapy in a bipolar II patient Author(s): Selek S, Savas HA, Savas E, Herken H, Tutkun H, Gergerlioglu HS Source: INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE 9 (1): 65-67 MAR 2005 Document Type: Article Language: English Cited References: 14 Times Cited: 2 1. Selek S, Haluk SA About lamotrigine and its hepatic effects CNS SPECTRUMS 10 (7): 522-522 JUL 2005 2. Savas HA, Selek S, Bulbu F, et al.Successful treatment with lamotrigine in bipolar depression: a study from Turkey AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY 40 (5): 498-500 MAY 2006 Title: Relationship between alexithymia, dissociation and anxiety in psychiatric outpatients from Turkey Author(s): Tutkun H, Savas HA, Zoroglu SS, Esgi K, Herken H, Tiryaki N Source: ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES 41 (2): 118-124 2004 Document Type: Article Language: English Cited References: 27 Times Cited: 1 1. Sar V The scope of dissociative disorders: An international perspective PSYCHIATRIC CLINICS OF NORTH AMERICA 29 (1): 227+ MAR 2006 Title: The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia Author(s): Zoroglu SS, Herken H, Yurekli M, Uz E, Tutkun H, Savas HA, Bagci C, Ozen ME, Cengiz B, Cakmak EA, Dogru MI, Akyol O Source: JOURNAL OF PSYCHIATRIC RESEARCH 36 (5): 309-315 SEP-OCT 2002 Document Type: Article Language: English Cited References: 50 Times Cited: 13 1. Yilmaz N, Herken H, Cicek HK, et al.Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia MEDICAL PRINCIPLES AND PRACTICE 16 (2): 137-141 2007 2.Herken H, Gurel A, Selek S, et al.Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: Impact of antidepressant treatment ARCHIVES OF MEDICAL RESEARCH 38 (2): 247-252 FEB 2007 3. Atmaca M, Tezcan E, Ustundag B Plasma nitric oxide and leptin values in patients with olanzapine-induced weight gain JOURNAL OF PSYCHIATRIC RESEARCH 41 (1-2): 74-79 JAN-FEB 2007 4. Perez-Neri I, Ramirez-Bermudez J, Montes S, et al.Possible mechanisms of neurodegeneration in schizophrenia NEUROCHEMICAL RESEARCH 31 (10): 1279-1294 OCT 2006 5. Ustundag B, Atmaca M, Kirtas O, et al.Total antioxidant response in patients with schizophrenia PSYCHIATRY AND CLINICAL NEUROSCIENCES 60 (4): 458-464 AUG 2006 6. Savas HA, Gergerlioglu HS, Armutcu F, et al.Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: Impact of past episodes WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY 7 (1): 51-55 2006 7. Herken H, Akyol O, Yilmaz HR, et al.Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL 21 (1): 53-59 JAN 2006 8. Bernstein HG, Bogerts B, Keilhoff G The many faces of nitric oxide in schizophrenia. A review SCHIZOPHRENIA RESEARCH 78 (1): 69-86 OCT 1 2005 9. Taneli F, Pirildar S, Akdeniz F, et al.Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia ARCHIVES OF MEDICAL RESEARCH 35 (5): 401-405 SEP-OCT 2004 10. Huang CH, Chen ML, Tsai YL, et al.Elevated adrenomedullin mRNA in lymphoblastoid cells from schizophrenic patients NEUROREPORT 15 (9): 1443-1446 JUN 28 2004 11. Akyol O, Zoroglu SS, Armutcu F, et al.Nitric oxide as a physiopathological factor in neuropsychiatric disorders IN VIVO 18 (3): 377-390 MAY-JUN 2004 12. Ben-Shachar D, Laifenfeld D Mitochondria, synaptic plasticity, and schizophrenia INTERNATIONAL REVIEW OF NEUROBIOLOGY 59: 273-296 2004 13. Yanik M, Vural H, Tutkun H, et al.The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 254 (1): 43-47 FEB 2004 Title: The protective effects of omega-3 fatty acids against MK-801-induced neurotoxicity in prefrontal cortex of rat Author(s): Ozyurt B (Ozyurt, Birsen), Sarsilmaz M (Sarsilmaz, Mustafa), Akpolat N (Akpolat, Nusret), Ozyurt H (Ozyurt, Huseyin), Akyol O (Akyol, Omer), Herken H (Herken, Hasan), Kus I (Kus, Ilter) Source: NEUROCHEMISTRY INTERNATIONAL 50 (1): 196-202 JAN 2007 Document Type: Article Language: English Cited References: 59 Times Cited: 1 1. Lieberman, Perkins, Jarskog An expert review of clinical challenges in psychiatry – Question-and-answer forum CNS SPECTRUMS 12 (3): A13-A13 MAR 2007 Title: Psychophysical responses to experimentally induced heat and cold pain before, during, and after transcutaneous electrical nerve stimulation Author(s): Tulgar M, Tulgar O, Herken H Source: NEUROMODULATION 6 (4): 229-236 OCT 2003 Document Type: Article Language: English Cited References: 14 Times Cited: 1 1. Kalkan E, Arican M, Kalkan SS, et al.A new neuroimplantable device: The tulgar implant. Initial results of animal testing NEUROMODULATION 8 (4): 249-256 OCT 2005 Title: T102C polymorphisms at the 5-HT2A receptor gene in Turkish schizophrenia patients: A possible association with prognosis Author(s): Herken H, Erdal ME, Erdal N, Aynacioglu S Source: NEUROPSYCHOBIOLOGY 47 (1): 27-30 2003 Document Type: Article Language: English Cited References: 15 Times Cited: 5 1. Cho IH, Yoo HJ, Park M, et al.Family-based association study of 5-HTTLPFL and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios BRAIN RESEARCH 1139: 34-41 MAR 30 2007 2. Liu LB, Hu Y, Ju GZ, et al.Is KPNB3 locus associated with schizophrenia? BIOMEDICAL AND ENVIRONMENTAL SCIENCES 20 (1): 52-55 FEB 2007 3. Li DW, Duan Y, He L Association study of serotonin 2A receptor (5-HT2A) gene with schizophrenia and suicidal behavior using systematic meta-analysis BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 340 (3): 1006-1015 FEB 17 2006 4. Wei J, Hemmings GP The KPNA3 gene may be a susceptibility candidate for schizophrenia NEUROSCIENCE RESEARCH 52 (4): 342-346 AUG 2005 5. Zhang XN, Jiang SD, He XH, et al.102T/C SNP in the 5-hydroxytryptamine receptor 2A (HTR2A) gene and schizophrenia in two southern Han Chinese populations: Lack of association AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 126B (1): 16-18 APR 1 2004 Title: Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia? Author(s): Yanik M, Vural H, Kocyigit A, Tutkun H, Zoroglu SS, Herken H, Savas HA, Koylu A, Akyol O Source: NEUROPSYCHOBIOLOGY 47 (2): 61-65 2003 Document Type: Article Language: English Cited References: 28 Times Cited: 11 1. Hou Y, Wu CF, Yang JY, et al.Effects of clozapine, olanzapine and haloperidol on nitric oxide production by lipopolysaccharide-activated N9 cells PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 30 (8): 1523-1528 DEC 30 2006 2. Perez-Neri I, Ramirez-Bermudez J, Montes S, et al.Possible mechanisms of neurodegeneration in schizophrenia NEUROCHEMICAL RESEARCH 31 (10): 1279-1294 OCT 2006 3. Vannacci A, Ravaldi C, Giannini L, et al.Increased nitric oxide production in eating disorders NEUROSCIENCE LETTERS 399 (3): 230-233 MAY 22 2006 4. Bernstein HG, Bogerts B, Keilhoff G The many faces of nitric oxide in schizophrenia. A review SCHIZOPHRENIA RESEARCH 78 (1): 69-86 OCT 1 2005 5. Taneli F, Pirildar S, Akdeniz F, et al.Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia ARCHIVES OF MEDICAL RESEARCH 35 (5): 401-405 SEP-OCT 2004 6. Yanik M, Erel O, Kati M The relationship between potency of oxidative stress and severity of depression ACTA NEUROPSYCHIATRICA 16 (4): 200-203 AUG 2004 7. Manto MU, Fatemi H Nitric oxide in the cerebellum of mutant mice CEREBELLUM 3 (3): 130-132 2004 8. Akyol O, Zoroglu SS, Armutcu F, et al.Nitric oxide as a physiopathological factor in neuropsychiatric disorders IN VIVO 18 (3): 377-390 MAY-JUN 2004 9. Keilhoff G, Becker A, Grecksch G, et al.Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human Schizophrenia NEUROSCIENCE 126 (3): 591-598 2004 10. Ben-Shachar D, Laifenfeld D Mitochondria, synaptic plasticity, and schizophrenia INTERNATIONAL REVIEW OF NEUROBIOLOGY 59: 273-296 2004 11. Yanik M, Vural H, Tutkun H, et al.The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 254 (1): 43-47 FEB 2004 Title: Hippocampal volume in schizophrenia and its relationship with risperidone treatment: A stereological study Author(s): Savas HA, Unal B, Erbagci H, Inaloz S, Herken H, Canan S, Gumusburun E, Zoroglu SS Source: NEUROPSYCHOBIOLOGY 46 (2): 61-66 2002 Document Type: Article Language: English Cited References: 40 Times Cited: 7 1. Aydinli B, Kantarci M, Polat KY, et al.Stereological evaluation of treatment response in patients with non-resectable hepatic alveolar echinococcosis using computed tomography via the Cavalieri method LIVER INTERNATIONAL 26 (10): 1234-1240 DEC 2006 2. Alper F, Kantarci M, Altunkaynak E, et al.Quantitative magnetic resonance imaging of brainstem volumes, plaques, and surface area in the occipital regions of patients with multiple sclerosis ACTA RADIOLOGICA 47 (4): 413-418 JUL 2006 3. Okur A, Kantarci M, Akgun M, et al.Unbiased estimation of tumor regression rates during chemoradiotherapy for esophageal carcinoma using CT and stereology DISEASES OF THE ESOPHAGUS 18 (2): 114-119 2005 4. Unal B, Tan HY, Orbak Z, et al.Morphological alterations produced by zinc deficiency in rat sciatic nerve: A histological, electron microscopic, and stereological study BRAIN RESEARCH 1048 (1-2): 228-234 JUN 28 2005 5. Geuze E, Vermetten E, Bremner JD MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders MOLECULAR PSYCHIATRY 10 (2): 160-184 FEB 2005 6. Gepdiremen A, Aydin N, Halici Z, et al.Chronic treatment of haloperidol causes vasoconstriction on basilar arteries of rats, dose dependently PHARMACOLOGICAL RESEARCH 50 (6): 569-574 DEC 2004 7. Unal B, Ozbek ME, Aydin MD, et al.Effect of haloperidol on the numerical density of neurons and nuclear height in the rat hippocampus – (A stereological and histopathological study) NEUROSCIENCE RESEARCH COMMUNICATIONS 34 (1): 1-9 JAN-FEB 2004 Title: Possible role of nitric oxide and adrenomedullin in bipolar affective disorder Author(s): Savas HA, Herken H, Yurekli M, Uz E, Tutkun H, Zoroglu SS, Ozen ME, Cengiz B, Akyol O Source: NEUROPSYCHOBIOLOGY 45 (2): 57-61 2002 Document Type: Article Language: English Cited References: 37 Times Cited: 17 1. Herken H, Gurel A, Selek S, et al.Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: Impact of antidepressant treatment ARCHIVES OF MEDICAL RESEARCH 38 (2): 247-252 FEB 2007 2. Hoekstra R, Fekkes D, Pepplinkhuizen L, et al.Nitric oxide and neopterin in bipolar affective disorder NEUROPSYCHOBIOLOGY 54 (1): 75-81 2006 3. Tas FV, Guvenir T, Tas G, et al.Nitric oxide levels in disruptive behavioral disorder NEUROPSYCHOBIOLOGY 53 (4): 176-180 2006 4. Yurekli M, Yarpuzlu AA The investigation of levels of the peptide adrenomedullin (ADM) and the enzyme tyrosine hydroxylase (TH) in rat tissue after exposure to physiological stress STRESS AND HEALTH 22 (2): 71-80 APR 2006 5. Savas HA, Gergerlioglu HS, Armutcu F, et al.Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: Impact of past episodes WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY 7 (1): 51-55 2006 6. Herken H, Akyol O, Yilmaz HR, et al.Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL 21 (1): 53-59 JAN 2006 7. Reif A, Strobel A, Jacob CP, et al.A NOS-III haplotype that includes functional polymorphisms is associated with bipolar disorder INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 9 (1): 13-20 FEB 2006 8. Bernstein HG, Bogerts B, Keilhoff G The many faces of nitric oxide in schizophrenia. A review SCHIZOPHRENIA RESEARCH 78 (1): 69-86 OCT 1 2005 9. Yuksel N, Uzbay IT, Karakilic H, et al.(I)ncreased serum nitrite/nitrate (NOx) and malondialdehyde (MDA) levels during alcohol withdrawal in alcoholic patients PHARMACOPSYCHIATRY 38 (2): 95-96 MAR 2005 10. Yanik M, Erel O, Kati M The relationship between potency of oxidative stress and severity of depression ACTA NEUROPSYCHIATRICA 16 (4): 200-203 AUG 2004 11. Huang CH, Chen ML, Tsai YL, et al.Elevated adrenomedullin mRNA in lymphoblastoid cells from schizophrenic patients NEUROREPORT 15 (9): 1443-1446 JUN 28 2004 12. Akyol O, Zoroglu SS, Armutcu F, et al.Nitric oxide as a physiopathological factor in neuropsychiatric disorders IN VIVO 18 (3): 377-390 MAY-JUN 2004 13. Keilhoff G, Becker A, Grecksch G, et al.Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human Schizophrenia NEUROSCIENCE 126 (3): 591-598 2004 14. Yanik M, Vural H, Tutkun H, et al.The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 254 (1): 43-47 FEB 2004 15. Yuksel S, Yurekli M The effect of adrenomedullin (ADM) on tyrosine hydroxylase (TH) enzyme activity and blood pressure in cold exposed rats ENDOCRINE JOURNAL 50 (5): 553-559 OCT 2003 16. Sogut S, Zoroglu SS, Ozyurt H, et al.Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism CLINICA CHIMICA ACTA 331 (1-2): 111-117 MAY 2003 17. Zoroglu SS, Yurekli M, Meram I, et al.Pathophysiological role of nitric oxide and adrenomedullin in autism CELL BIOCHEMISTRY AND FUNCTION 21 (1): 55-60 MAR 2003 Title: Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder Author(s): Zoroglu SS, Erdal ME, Alasehirli B, Erdal N, Sivasli E, Tutkun H, Savas HA, Herken H Source: NEUROPSYCHOBIOLOGY 45 (4): 176-181 2002 Document Type: Article Language: English Cited References: 49 Times Cited: 31 1. Heiser P, Dempfle A, Friedel S, et al.Family-based association study of serotonergic candidate genes and attention-deficit/hyperactivity disorder in a German sample JOURNAL OF NEURAL TRANSMISSION 114 (4): 513-521 APR 2007 2. Li J, Wang YF, Zhou RL, et al.Association between polymorphisms in serotonin transporter gene and attention deficit hyperactivity disorder in Chinese han subjects AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 144B (1): 14-19 JAN 5 2007 3. Schimmelmann BG, Friedel S, Christiansen H, et al.Genetic findings in Attention-Deficit and Hyperactivity Disorder (ADHD) ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE 34 (6): 425+ NOV 2006 4. Brune CW, Kim SJ, Salt J, et al.5-HTTLPR genotype-specific phenotype in children and adolescents with autism AMERICAN JOURNAL OF PSYCHIATRY 163 (12): 2148-2156 DEC 2006 5. Li J, Zhang X, Wang YF, et al.The serotonin 5-HT1D receptor gene and attention-deficit hyperactivity disorder in Chinese Han subjects AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 141B (8): 874-876 DEC 5 2006 6. Bobb AJ, Castellanos FX, Addington AM, et al.Molecular genetic studies of ADHD: 1991 to 2004 AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 141B (6): 551-565 SEP 5 2006 7. Li J, Wang YF, Zhou RL, et al.No association of attention-deficit/hyperactivity disorder with genes of the serotonergic pathway in Han Chinese subjects NEUROSCIENCE LETTERS 403 (1-2): 172-175 JUL 31 206 8. Waldman ID, Gizer IR The genetics of attention deficit hyperactivity disorder CLINICAL PSYCHOLOGY REVIEW 26 (4): 396-432 AUG 006 9. Reuter M, Kirsch P, Hennig J Inferring candidate genes for Attention Deficit Hyperactivity Disorder (ADHD) assessed by the World Health Organization Adult ADHD Self-Report Scale (ASRS) JOURNAL OF NEURAL TRANSMISSION 113 (7): 929-93 JUL 2006 10. Li J, Wang YF, Zhou RL, et al.Association of attention-deficit/hyperactivity disorder with serotonin 4 receptor gene polymorphisms in Han Chinese subjects NEUROSCIENCE LETTERS 401 (1-2): 6-9 JUN 19 2006 11. Banerjee E, Sinha S, Chatterjee A, et al.A family-based study of Indian subjects from Kolkata reveals allelic association of the serotonin transporter intron-2 (STin2) polymorphism and attention-deficit-hyperactivity disorder (ADHD) AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 141B (4): 361-366 JUN 5 2006 12. Weiss M, Hechtman L A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults JOURNAL OF CLINICAL PSYCHIATRY 67 (4): 611-619 APR 2006 13. Li J, Wang YF, Zhou RL, et al.Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder in Chinese Han population AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 141B (2): 126-129 MAR 5 2006 14. Wohl M, Purper-Ouakil D, Mouren MC, et al.Meta-analysis of candidate genes in attention-deficithyperactivity disorder ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE 31 (4): 437-447 Part 1 JUL-AUG 2005 15. Thapar A, O’Donovan M, Owen MJ The genetics of attention deficit hyperactivity disorder HUMAN MOLECULAR GENETICS 14: R275-R282 Sp. Iss. 2 OCT 15 2005 16. Xu XH, Mill J, Chen CK, et al.Family-based association study of serotonin transporter gene polymorphisms in attention deficit hyperactivity disorder: No evidence for association in UK and Taiwanese samples AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 139B (1): 11-13 NOV 5 2005 17. Kim SJ, Badner J, Cheon KA, et al.Family-based association study of the serotonin transporter gene polymorphisms in Korean ADHD trios AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 139B (1): 14-18 NOV 5 2005 18. Olsson CA, Byrnes GB, Lotfi-Miri M, et al.Association between 5-HTTLPR genotypes and persisting patterns of anxiety and alcohol use: results from a 10-year longitudinal study of adolescent mental health MOLECULAR PSYCHIATRY 10 (9): 868-876 SEP 2005 19. Zhao AL, Su LY, Zhang YH, et al.Association analysis of serotonin transporter promoter gene polymorphism with ADHD and related symptomatology INTERNATIONAL JOURNAL OF NEUROSCIENCE 115 (8): 1183-1191 AUG 2005 20. Faraone SV, Perlis RH, Doyle AE, et al.Molecular genetics of attention-deficit/hyperactivity disorder BIOLOGICAL PSYCHIATRY 57 (11): 1313-1323 JUN 1 2005 21. Wodarz N, Lange K, Laufkotter R, et al.ADHD and alcohol dependence: A common genetic predisposition? PSYCHIATRISCHE PRAXIS 31: S111-S113 Suppl. 1 NOV 2004 22. Bobb AJ, Castellanos FX, Addington AM, et al.Molecular genetic studies of ADHD: 1991 to 2004 AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 132B (1): 109-125 JAN 5 2005 23. Heiser P, Friedel S, Dempfle A, et al.Molecular genetic aspects of attention-deficit/hyperactivity disorder NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS 28 (6): 625-641 OCT 2004 24. Davidge KM, Atkinson L, Douglas L, et al.Association of the serotionin transporter and 5HT1D beta receptor genes with extreme, persistent and pervasive aggressive behaviour in children PSYCHIATRIC GENETICS 14 (3): 143-146 SEP 2004 25. Asherson P Attention-deficit hyperactivity disorder in the post-genomic era EUROPEAN CHILD & ADOLESCENT PSYCHIATRY 13: I50-I70 Suppl. 1 JUL 2004 26. Seeger G, Schloss P, Schmidt MH, et al.Gene-environment interaction in hyperkinetic conduct disorder (HD+CD) as indicated by season of birth variations in dopamine receptor (DRD4) gene polymorphism NEUROSCIENCE LETTERS 366 (3): 282-286 AUG 19 2004 27. Beitchman JH, Davidge KM, Kennedy JL, et al.The serotonin transporter gene in aggressive children with and without ADHD and nonaggressive matched controls ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 1008: 248-251 2003 28. Johann M, Bobbe G, Putzhammer A, et al.Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: Differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor) ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 27 (10): 1527-1534 OCT 2003 29. Galili-Weisstub E, Segman RH Attention Deficit and Hyperactivity Disorder: Review of genetic association studies ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES 40 (1): 57-66 2003 30. Zoroglu SS, Erdal ME, Erdal N, et al.No evidence for an association between the T102C and 1438 G/A polymorphisms of the serotonin 2A receptor gene in attention deficit/hyperactivity disorder in a Turkish population NEUROPSYCHOBIOLOGY 47 (1): 17-20 2003 31. Melke J Serotonin transporter gene polymorphisms and mental health CURRENT OPINION IN PSYCHIATRY 16 (2): 215-220 MAR 2003 Title: T102C polymorphism of the 5-HT2A receptor gene may be associated with temporomandibular dysfunction Author(s): Mutlu N, Erdal ME, Herken H, Oz G, Bayazit YA Source: ORAL DISEASES 10 (6): 349-352 NOV 2004 Document Type: Article Language: English Cited References: 15 Times Cited: 3 1. Buskila D, Sarzi-Puttini P, Ablin JN The genetics of fibromyalgia syndrome PHARMACOGENOMICS 8 (1): 67-74 JAN 2007 2. Fukuda Y, Koga M, Arai M, et al.Monoallelic and unequal allelic expression of the HTR2A gene in human brain and peripheral lymphocytes BIOLOGICAL PSYCHIATRY 60 (12): 1331-1335 DEC 15 2006 3. Bayazit YA, Yilmaz M, Ciftci T, et al.Association of the-1438G/A polymorphism of the 5-HT2A receptor gene with obstructive sleep apnea syndrome ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES 68 (3): 123-128 2006 Title: The 1438G/A polymorphism of the 5-HT2A receptor gene is associated with aura in migraine Author(s): Erdal ME, Yilmaz M, Herken H, Kocoglu H, Bayazit YA Source: PAIN CLINIC 15 (3): 315-319 2003 Document Type: Article Language: English Cited References: 19 Times Cited: 2 1.Erdal N, Herken H, Yilmaz M, et al.The A218C polymorphism of tryptophan hydroxylase gene and migraine JOURNAL OF CLINICAL NEUROSCIENCE 14 (3): 249-251 MAR 2007 2.Bayazit YA, Yilmaz M, Ciftci T, et al.Association of the-1438G/A polymorphism of the 5-HT2A receptor gene with obstructive sleep apnea syndrome ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES 68 (3): 123-128 2006 Title: Associations between Mn-SOD genetic polymorphism and schizophrenia Author(s): Akyol O, Elyas H, Canatan H, Akin H, Yuce H, Yanik M, Namli M, Yilmaz HR, Tutkun H, Herken H, Savas HA, Zoroglu SS, Sogut S, Ozyurt H Source: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 30 (4): 761-761 JUN 2006 Document Type: Letter Language: English Cited References: 4 Times Cited: 3 1. Mostowska A, Hozyasz KK, Lianeri M, et al.Polymorphic variants of genes encoding main antioxidant enzymes and the risk of CL/P-affected pregnancies CLINICAL BIOCHEMISTRY 40 (5-6): 416-419 MAR 2007 2. Ventriglia M, Scassellati C, Bonvicini C, et al.No association between Ala9Val functional polymorphism of MnSOD gene and schizophrenia in a representative Italian sample NEUROSCIENCE LETTERS 410 (3): 208-211 DEC 27 2006 3. Akyol O, Elyas H, Canatan H, et al.Associations between Mn-SOD polymorphism and schizophrenia (vol 30, pg 761, 2006) PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 30 (6): 1187-1187 AUG 30 2006 Title: Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia Author(s): Akyol O, Yanik M, Elyas H, Namli M, Canatan H, Akin H, Yuce H, Yilmaz HR, Tutkun H, Sogut S, Herken H, Ozyurt H, Savas HA, Zoroglu SS Source: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 29 (1): 123-131 JAN 2005 Document Type: Review Language: English Cited References: 39 Times Cited: 6 1. Yuce H, Hepsen IF, Tekederei I, et al.Lack of association between pseudoexfoliation syndrome and manganese superoxide dismutase polymorphism CURRENT EYE RESEARCH 32 (4): 387-391 APR 2007 2. Ventriglia M, Scassellati C, Bonvicini C, et al.No association between Ala9Val functional polymorphism of MnSOD gene and schizophrenia in a representative Italian sample NEUROSCIENCE LETTERS 410 (3): 208-211 DEC 27 2006 3. Perez-Neri I, Ramirez-Bermudez J, Montes S, et al.Possible mechanisms of neurodegeneration in schizophrenia NEUROCHEMICAL RESEARCH 31 (10): 1279-1294 OCT 2006 4. Pae CU, Yoon SJ, Patkar A, et al. Manganese superoxide dismutase (MnSOD : Ala-9Val) gene polymorphism and mood-disorders: A preliminary study PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 30 (7): 1326-1329 SEP 30 2006 5. Akyol O, Elyas H, Canatan H, et al.Associations between Mn-SOD genetic polymorphism and schizophrenia PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 30 (4): 761-761 JUN 2006 6. Pae CU Comments on “Association between Ala-9Val polymorphism of MnSOD gene and schizophrenia” by O. Akyol et al. Progress in Neuropsychopharmacology and Biological Psychiatry 29, 2005, 123-131 PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 30 (4): 762-763 JUN 2006 Title: The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients The possible role of oxidant/antioxidant imbalance Author(s): Akyol O, Herken H, Uz E, Fadillioglu E, Unal S, Sogut S, Ozyurt H, Savas HA Source: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 26 (5): 995-1005 JUN 2002 Document Type: Review Language: English Cited References: 80 Times Cited: 48 1. Grignon S, Chianetta JM Assessment of malondialdehyde levels in schizophrenia: A meta-analysis and some methodological considerations PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 31 (2): 365-369 MAR 30 2007 2. Yilmaz N, Herken H, Cicek HK, et al.Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia MEDICAL PRINCIPLES AND PRACTICE 16 (2): 137-141 2007 3. Herken H, Gurel A, Selek S, et al.Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: Impact of antidepressant treatment ARCHIVES OF MEDICAL RESEARCH 38 (2): 247-252 FEB 2007 4. Ozyurt B, Sarsilmaz M, Akpolat N, et al.The protective effects of omega-3 fatty acids against MK-801-induced neurotoxicity in prefrontal cortex of rat NEUROCHEMISTRY INTERNATIONAL 50 (1): 196-202 JAN 2007 5. Perez-Neri I, Ramirez-Bermudez J, Montes S, et al.Possible mechanisms of neurodegeneration in schizophrenia NEUROCHEMICAL RESEARCH 31 (10): 1279-1294 OCT 2006 6. Antalis CJ, Stevens LJ, Campbell M, et al.Omega-3 fatty acid status in attention-deficit/hyperactivity disorder PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS 75 (4-5): 299-308 OCT-NOV 2006 7. Altunoluk B, Soylemez H, Oguz F, et al.An angiotensin-converting enzyme inhibitor, zofenopril, prevents renal ischemia/reperfusion injury in rats ANNALS OF CLINICAL AND LABORATORY SCIENCE 36 (3): 326-332 SUM 2006 8. Tas FV, Guvenir T, Tas G, et al.Nitric oxide levels in disruptive behavioral disorder NEUROPSYCHOBIOLOGY 53 (4): 176-180 2006 9. Iraz M, Ozerol E, Gulec M, et al.Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat CELL BIOCHEMISTRY AND FUNCTION 24 (4): 357-361 JUL-AUG 2006 10. Ustundag B, Atmaca M, Kirtas O, et al.Total antioxidant response in patients with schizophrenia PSYCHIATRY AND CLINICAL NEUROSCIENCES 60 (4): 458-464 AUG 2006 11. Fendri C, Mechri A, Khiari G, et al.Oxidative stress involvement in schizophrenia pathophysiology : a review ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE 32 (2): 244-252 Part 1 MAR-APR 2006 12. Gama CS, Salvador M, Andreazza AC, et al.Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: A study of patients treated with haloperidol or clozapine PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 30 (3): 512-515 MAY 2006 13. Salum C, Guimaraes FS, Brandao ML, et al.Dopamine and nitric oxide interaction on the modulation of prepulse inhibition of the acoustic startle response in the Wistar rat PSYCHOPHARMACOLOGY 185 (2): 133-141 APR 2006 14. Sanchez-Rodriguez MA, Santiago E, Arronte-Rosales A, et al.Relationship between oxidative stress and cognitive impairment in the elderly of rural vs. urban communities LIFE SCIENCES 78 (15): 1682-1687 MAR 6 2006 15. Savas HA, Gergerlioglu HS, Armutcu F, et al.Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: Impact of past episodes WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY 7 (1): 51-55 2006 16. Erdogan H, Fadillioglu E, Yagmurca M, et al.Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine UROLOGICAL RESEARCH 34 (1): 41-46 FEB 2006 17. Zhang XY, Tan YL, Cao LY, et al.Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics SCHIZOPHRENIA RESEARCH 81 (2-3): 291-300 JAN 31 2006 18. Herken H, Akyol O, Yilmaz HR, et al.Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL 21 (1): 53-59 JAN 2006 19. Jordan W, Cohrs S, Degner D, et al.Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome JOURNAL OF NEURAL TRANSMISSION 113 (2): 239-254 FEB 2006 20. Atmaca M, Tezcan E, Kuloglu M, et al.Plasma nitrate values in patients with obsessive-compulsive disorder PSYCHIATRY AND CLINICAL NEUROSCIENCES 59 (5): 621-623 OCT 2005 21. Koc A, Duru M, Ciralik H, et al.Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats MOLECULAR AND CELLULAR BIOCHEMISTRY 278 (1-2): 79-84 OCT 2005 22. Ilhan A, Gurel A, Armutcu F, et al.Antiepileptogenic and antioxidant effects of Nigella sativa oil against pentylenetetrazol-induced kindling in mice NEUROPHARMACOLOGY 49 (4): 456-464 SEP 2005 23. Ozturk E, Demirbilek S, But AK, et al.Antioxidant properties of propofol and erythropoietin after closed head injury in rats PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 29 (6): 920-925 JUL 2005 24. Wang HT, Xu HY, Dyck LE, et al.Olanzapine and quetiapine protect PC12 cells from beta-amyloid peptide(25-35)-induced oxidative stress and the ensuing apoptosis. JOURNAL OF NEUROSCIENCE RESEARCH 81 (4): 572-580 AUG 15 2005 25. Ozgocmen S, Ardicoglu O, Erdogan H, et al.In vivo effect of celecoxib and tenoxicam on oxidant/anti-oxidant status of patients with knee osteoarthritis ANNALS OF CLINICAL AND LABORATORY SCIENCE 35 (2): 137-143 SPR 2005 26. Taneli F, Pirildar S, Akdeniz F, et al.Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia ARCHIVES OF MEDICAL RESEARCH 35 (5): 401-405 SEP-OCT 2004 27. Akyol O, Yanik M, Elyas H, et al.Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 29 (1): 123-131 JAN 2005 28. Akdeniz N, Esrefoglu M, Keles MS, et al.Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet’s disease ANNALS ACADEMY OF MEDICINE SINGAPORE 33 (5): 596-599 SEP 2004 29. Pae CU, Yu HS, Kirm JJ, et al.Glutathione S-transferase M1 polymorphism may contribute to schizophrenia in the Korean population PSYCHIATRIC GENETICS 14 (3): 147-150 SEP 2004 30. Chauhan A, Chauhan V, Brown WT, et al.Oxidative stress in autism: Increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin – the antioxidant proteins LIFE SCIENCES 75 (21): 2539-2549 OCT 8 2004 31. Michel TM, Thome J, Martin D, et al.Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis JOURNAL OF NEURAL TRANSMISSION 111 (9): 1191-1201 SEP 2004 32. Songur A, Sarsilmaz M, Sogut S, et al.Hypothalamic superoxide dismutase, xanthine oxidase, nitric oxide, and malondialdehyde in rats fed with fish omega-3 fatty acids PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 28 (4): 693-698 JUL 2004 33. Kizilay A, Kalcioglu MT, Ozerol E, et al.Caffeic acid phenethyl ester ameliorated ototoxicity induced by cisplatin in rats JOURNAL OF CHEMOTHERAPY 16 (4): 381-387 AUG 2004 34. Akyol O, Zoroglu SS, Armutcu F, et al.Nitric oxide as a physiopathological factor in neuropsychiatric disorders IN VIVO 18 (3): 377-390 MAY-JUN 2004 35. Dakhale G, Khanzode S, Khanzode S, et al.Oxidative damage and schizophrenia: The potential benefit by atypical antipsychotics NEUROPSYCHOBIOLOGY 49 (4): 205-209 2004 36. Ben-Shachar D, Laifenfeld D Mitochondria, synaptic plasticity, and schizophrenia INTERNATIONAL REVIEW OF NEUROBIOLOGY 59: 273-296 2004 37. Yao JK, van Kammen DPMembrane phospholipids and cytokine interaction in schizophrenia INTERNATIONAL REVIEW OF NEUROBIOLOGY 59: 297-326 2004 38. Yanik M, Vural H, Tutkun H, et al.The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 254 (1): 43-47 FEB 2004 39. Aktan B, Taysi S, Gumustekin K, et al.Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion POLISH JOURNAL OF PHARMACOLOGY 55 (6): 1105-1110 NOV-DEC 2003 40. Kubota K, Ishibashi T, Matsubara T, et al.Effects of 4,4 ‘-diisothiocyanato-stilbene-2,2 ‘-disulfonic acid (DIDS) and chlorpromazine on NO3- transport via anion exchanger in erythrocytes: Inertness of DIDS in whole blood JOURNAL OF PHARMACOLOGICAL SCIENCES 93 (4): 505-508 DEC 2003 41. Ranjekar PK, Hinge A, Hegde MV, et al.Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients PSYCHIATRY RESEARCH 121 (2): 109-122 DEC 1 2003 42. Skosnik PD, Yao JK From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia? PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS 69 (6): 367-384 DEC 2003 43. Yao JK, Sistilli CG, van Kammen DPMembrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS 69 (6): 429-436 DEC 2003 44. Sarsimaz M, Songur A, Kus I, et al.The regulatory role of dietary omega-3 essential fatty acids on oxidant/antioxidant balance in rat hippocampus NEUROSCIENCE RESEARCH COMMUNICATIONS 33 (2): 114-123 SEP-OCT 2003 45. Fadillioglu E, Erdogan H, Iraz M, et al.Effects of caffeic acid phenethyl ester against doxorubicin-induced neuronal oxidant injury NEUROSCIENCE RESEARCH COMMUNICATIONS 33 (2): 132-138 SEP-OCT 2003 46. Sarsilmaz M, Songur A, Ozyurt H, et al.Potential role of dietary omega-3 essential fatty acids on some oxidant/antioxidant parameters in rats’ corpus striatum PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS 69 (4): 253-259 OCT 2003 47. Tezcan E, Atmaca M, Kuloglu M, et al.Free radicals in patients with post-traumatic stress disorder EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 253 (2): 89-91 APR 2003 48. Fadillioglu E, Erdogan H Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats PHARMACOLOGICAL RESEARCH 47 (4): 317-322 APR 2003 Title: Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome Author(s): Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N Source: RHEUMATOLOGY INTERNATIONAL 23 (3): 104-107 MAY 2003 Document Type: Article Language: English Cited References: 15 Times Cited: 18 1. Nackley AG, Tan KS, Fecho K, et al.Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta(2)- and beta(3)-adrenergic receptors PAIN 128 (3): 199-208 APR 2007 2. Van Houdenhove B, Luyten P Stress, depression and fibromyalgia ACTA NEUROLOGICA BELGICA 106 (4): 149-156 DEC 2006 3. Smith BH, Macfarlane GJ, Torrance N Epidemiology of chronic pain, from the laboratory to the bus stop: time to add understanding of biological mechanisms to the study of risk factors in population-based research? PAIN 127 (1-2): 5-10 JAN 2007 4. Buskila D, Sarzi-Puttini P, Ablin JN The genetics of fibromyalgia syndrome PHARMACOGENOMICS 8 (1): 67-74 JAN 2007 5. Diatchenko L, Nackley AG, Slade GD, et al.Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli PAIN 125 (3): 216-224 DEC 5 2006 6. Buskila D, Sarzi-Puttini P Genetic aspects of fibromyalgia syndrome ARTHRITIS RESEARCH & THERAPY 8 (5): Art. No. 218 2006 7. Ablin JN, Cohen H, Buskila D Mechanisms of Disease: genetics of fibromyalgia NATURE CLINICAL PRACTICE RHEUMATOLOGY 2 (12): 671-678 DEC 2006 8. Diatchenko L, Nackley AG, Slade GD, et al.Idiopathic pain disorders – Pathways of vulnerability PAIN 123 (3): 226-230 AUG 2006 9. Hagen K, Pettersen E, Stovner LJ, et al.No association between chronic musculoskeletal complaints and Val158Met polymorphism in the Catechol-O-methyltransferase gene. The HUNT study BMC MUSCULOSKELETAL DISORDERS 7: Art. No. 40 MAY 4 2006 10. Ablin JN, Buskila D The genetics of fibromyalgia – Closing Osler’s backdoor ISRAEL MEDICAL ASSOCIATION JOURNAL 8 (6): 428-429 JUN 2006 11. Ozgocmen S, Ozyurt H, Sogut S, et al.Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide RHEUMATOLOGY INTERNATIONAL 26 (7): 585-597 MAY 2006 12. Martinez-Lavin M Fibromyalgia is a neuropathic pain syndrome JOURNAL OF RHEUMATOLOGY 33 (4): 827-829 APR 2006 13. Bennett RM Three years later: Presidential address to MYOPAIN ’04 JOURNAL OF MUSCULOSKELETAL PAIN 12 (3-4): 1-12 2004 14. Russell IJ Developments in the fibromyalgia syndrome JOURNAL OF MUSCULOSKELETAL PAIN 12 (3-4): 47-57 2004 15. Mease P Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment JOURNAL OF RHEUMATOLOGY 32: 6-21 Suppl. 75 AUG 2005 16. Crofford LJ The relationship of fibromyalgia to neuropathic pain syndromes JOURNAL OF RHEUMATOLOGY 32: 41-45 Suppl. 75 AUG 2005 17. Buskila D, Neumann L, Press J Genetic factors in neuromuscular pain CNS SPECTRUMS 10 (4): 281-284 APR 2005 18. Goldenberg DL, Burckhardt C, Crofford L Management of fibromyalgia syndrome JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 292 (19): 2388-2395 NOV 17 2004 Title: Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: Impact of past episodes Author(s): Savas HA, Gergerlioglu HS, Armutcu F, Herken H, Yilmaz HR, Kocoglu E, Selek S, Tutkun H, Zoroglu SS, Akyol O Source: WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY 7 (1): 51-55 2006 Document Type: Article Language: English Cited References: 45 Times Cited: 1 1.Andreazza AC, Cassini C, Rosa AR, et al.Serum S100B and antioxidant enzymes in bipolar patients JOURNAL OF PSYCHIATRIC RESEARCH 41 (6): 523-529 SEP 2007 *Title: Absence of association of the serotonin transporter gene polymorphism with the mentally healthy subset of fibromyalgia patients (vol 21, pg 194, 2002)* *Author(s): Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B* *Source: CLINICAL RHEUMATOLOGY 21 (4): 351-351 AUG 2002* *Document Type: Correction* *Language: English* *Cited References: 1 Times Cited: 0* *Title: Absence of association of the serotonin transporter gene polymorphism with the mentally healthy subset of fibromyalgia patients* *Author(s): Gursoy S* *Source: CLINICAL RHEUMATOLOGY 21 (3): 194-197 JUN 2002* *Document Type: Article* *Language: English* *Cited References: 17 Times Cited: 18* 1. Buskila D, Sarzi-Puttini P, Ablin JN The genetics of fibromyalgia syndrome PHARMACOGENOMICS 8 (1): 67-74 JAN 2007 2. McBeth J, Silman AJ, Gupta A, et al.Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain – Findings of a population-based prospective cohort study ARTHRITIS AND RHEUMATISM 56 (1): 360-371 JAN 2007 3. Buskila D, Sarzi-Puttini P Genetic aspects of fibromyalgia syndrome ARTHRITIS RESEARCH & THERAPY 8 (5): Art. No. 218 2006 4. Serretti A, Calati R, Mandelli L, et al.Serotonin transporter gene variants and behavior: A comprehensive review CURRENT DRUG TARGETS 7 (12): 1659-1669 DEC 2006 5. Bazzichi L, Giannaccini G, Betti L, et al.Alteration of serotonin transporter density and activity in fibromyalgia ARTHRITIS RESEARCH & THERAPY 8 (4): Art. No. R99 2006 6. Arguelles LM, Afari N, Buchwald DS, et al.A twin study of posttraumatic stress disorder symptoms and chronic widespread pain PAIN 124 (1-2): 150-157 SEP 2006 7. Bennett RMThree years later: Presidential address to MYOPAIN ’04 JOURNAL OF MUSCULOSKELETAL PAIN 12 (3-4): 1-12 2004 8. Crofford LJ The relationship of fibromyalgia to neuropathic pain syndromes JOURNAL OF RHEUMATOLOGY 32: 41-45 Suppl. 75 AUG 2005 9. Buskila D, Neumann L, Press J Genetic factors in neuromuscular pain CNS SPECTRUMS 10 (4): 281-284 APR 2005 10. Raphael KG, Janal MN, Nayak S, et al.Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses PAIN 110 (1-2): 449-460 JUL 2004 11. Frank B, Niesler B, Bondy B, et al.Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients CLINICAL RHEUMATOLOGY 23 (4): 338-344 AUG 2004 12. Egle UT, Ecker-Egle ML, Nickel R, et al.Attention-deficit/hyperactivity disorder (ADHS) in adulthood PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE 54 (3-4): 137-147 MAR-APR 2004 13. Arnold LM, Hudson JI, Hess EV, et al.Family study of fibromyalgia ARTHRITIS AND RHEUMATISM 50 (3): 944-952 MAR 2004 14. Raphael KG, Janal MN, Nayak S Comorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of women PAIN MEDICINE 5 (1): 33-41 MAR 2004 15. Rubinow A Fibromyalgia: A distinct entity? ISRAEL MEDICAL ASSOCIATION JOURNAL 5 (12): 885-886 DEC 2003 16. Marcus DA Current trends in fibromyalgia research EXPERT OPINION ON PHARMACOTHERAPY 4 (10): 1687-1695 OCT 2003 17. Briley M, Moret C Fibromyalgia syndrome: An overview of potential drug targets IDRUGS 6 (7): 668-673 JUL 2003 18. Gursoy S, Erdal E, Herken H, et al.Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome RHEUMATOLOGY INTERNATIONAL 23 (3): 104-107 MAY 2003
b.
A.6
Ulusal Hakemli dergilerde yeralan
a.	1.Aşkın R, Polat H, Karaca S, Herken H, Doğan E, Yeksan M, Türk S. Diyaliz hastalarında görülen ruhsal sorunlar. İç Anadolu Tıp Dergisi 1995;5:61-64. 2.Gidiş D, Karaca S, Demir O, Aşkın R, Herken H, İlhan N. Epilepsi hastalarının Normal Kişilere göre ruhsal belirti düzeyleri ile stresle başa çıkma arasındaki ilişki. Nöropsikiyatri Gündemi 1996;1:1-4. 3.Herken H, Özkan İ, Bodur S, Kaya N, Turan M, Aşkın R. Gençlerde sigara kullanma davranışında anne baba tutumunun ve demografik özelliklerin ilişkisi.Genel Tıp Dergisi 1997;7:189-193. 4.Kaya N, Çilli A.Ş, Aşkın R, Herken H, Özkan İ, Kucur R. Orta öğrenim ve üniversite öğrencilerinde sosyal fobi belirti yaygınlığı. Genel Tıp Dergisi 1997;7:133-137. 5.Arıbaş ET, Kaya N, Herken H, Erayman İ, Bitirgen M. Psikiyatri hastalarında Hepatit B sıklığı. T Klin J Gastroenterohepotol 1997;8:18-23. 6.Herken H, Bodur S. Genç kızlarda kişilik ve ruhsal belirti düzeyini etkileyen bazı faktörler. Yeni Symposium 1998;3-4:76-80 7.Herken H, Karaca S, Özkan İ, Bodur S. Konya Kırsal Alanında Kocası Yurt Dışında Çalışan Kadınların Ruhsal Sorunları. S.Ü. T. F. Derg. 1998;14:159-163. 8.Herken H, Özkan İ, Beşiroğlu L, Derman H, Kaya N: Klozapin ve sülpiridin pozitif ve negatif belirtiler üzerine etkinliğinin karşılaştırılması. Klinik Psikofarmakoloji Bülteni 1998;4:244-248. 1999 yılına ait yayınlar 9.Herken H, Tiftik AM, Kaya N, Haliloğlu S, Dağlar C, Gederet Y. Bilişsel Değişiklikler ile Serbest Radikal ve Oksidatif Savunma Mekanizmaları Arasındaki ilişki. Düşünen Adam 1999;4:16-22. 10.Mutlu MN, Herken H, Küçükkolbaşı H, Turan M, Öztürk A. Nokturnal Bruksizm ile Ruhsal Belirti Arası İlişki. T Klin Diş Hek Bil 1999;15:154-158. 11.Turan M, Çilli AS, Aşkın R, Herken H, Telcioğlu M, Kucur R. CAGE Testi ile Alkol Kullanımı Üzerine Epidemiyolojik Bir Çalışma Klinik Psikiyatri 1999; 2:217-221. 12.Mutlu N, Herken H, Küçükkolbaşı H,Turan M, Tekin A. Diş Hekimliği Fakültesi Öğrencilerinde Myofasiyal Ağrı Sendromunun Psikometrik Açıdan Değerlendirilmesi Türk Oral ve Maksillofasiyal Cerrahi Derneği Dergisi1999;2:42-46. 13.Karaca S, Demir F, Herken H, Demir O, Aşkın R. Kronik ağrılı ve Migrenli hastalarda Depresyon Düzeyleri ve ağrı ile Başaçıkma Becerileri. Düşünen Adam. 1999;4:31-33. 14.Herken H, Kaya N,Beşiroğlu L, Derman H, Özkan İ. Kronik Şizofreni hastalarında Klozapin ve Sulpiridin etkinliğinin karşılaştırılması. Klinik Psikofarmakoloji Bülteni 1999;9:148-151. 15.Karaca S, Aşkın R, Herken H. Depresyonda Bilişsel Özellikler ile Beck Depresyon ölçeği ve Otomatik Düşünce Ölçeğinin Depresif hastaların belirlenmesindeki özgüllükleri. Yeni Symposium 1999;1-2:6-11. 2000 yılına ait yayınlar 16.Herken H, Özkan İ, Çilli AS, Telcioğlu M, Kucur R. Sigara Kullanma Davranışında Sosyal Öğrenmenin Etkisi 2000;Bağımlılık Dergisi 1:38-43. 17.Neyal M, Herken H, Demirci H, Vırıt O, Neyal A. Migren hastalarında Aleksitimi. Anadolu Tıp Dergisi 2000;2;129-134. 18.Herken H, Aşkın R, Karaca S, Doğan E, Yeksan M, Türk S, Alıcı S. Psychiatric symptom level and the ways of coping with the stress in dialysis patients. Anadolu Tıp Dergisi.2000;3:206-211. 19.Herken H, Neyal M, Yetkin Ö,Hengirmen A, Esgi K, Neyal A. Epilepsi Hastalarının Kişilik Özelliklerinin değerlendirilmesi. Anadolu Tıp Dergisi. 2000;3:200-205. 20.Turan M, Çilli AŞ, Aşkın R, Herken H, Kaya N, Kucur R. Sosyal fobinin diğer psikiyatrik hastalıklarla birlikteliği. Klinik Psikiyatri 2000;3:170-176. 21.Gidiş D,Kaya N, Şahinoğlu U,Çilli AS, Herken H, Özkan İ. İntihar girişiminde bulunan olgularda kolesterol ve trigliserit düzeyleri. Düşünen Adam. 2000;2:92-95. 22.Turan M, Herken H, Oran B. Down Sendromlu Çocuğu Olan Anne Babaların gereksinimlerinin Belirlenmesi.Türkiye’de Psikiyatri 2000;1:21-29. 23.Meram İ, Herken H, Ahi S, Tarakçıoğlu M. Şizofreni Hastalarında Serum Bakır ve Çinko Düzeyleri ve Enzimatik Olmayan Antioksidan Savunma Sistemi Türkiye’de Psikiyatri2000;2:129-135. 24.Herken H, Özkan İ,Çilli AS,Bodur S. Öğrencilerde alkol kullanım sıklığı ve sosyal öğrenme ile ilişkisi Düşünen Adam. 2000;2:87-91. 25.Herken H, Bodur S,Kara F. Sigara alkol ve madde kullanımı ile kişilik ve ruhsal belirti ilişkisi. Klinik Psikiyatri 2000;3:40-45. 26.Herken H, Turan M, Şenol S, Karaca S. Down Sendromlu Çocuğu Olan Anne Babaların Depresyon Düzeyleri ve Başaçıkma Biçimleri. Çocuk ve Gençlik Ruh Sağlığı Dergisi 2000;3:143-152. 2001 yılına ait yayınlar 27.Herken H, Aynacıoğlu AŞ, Koray Esgi, Vırıt O. Psikiyatri Hastalarında Sitokrom P 450 2D6 Enzim Hızları. Türk Psikiyatri Dergisi 2001;2:83-88. 28.Herken H, Erdal E, Esgi K, Barlas O, Erdal N, Aynacioğlu AS. Şizofrenili hastalarda serotonin transporter gen polimorfizmi.Klinik Psikofarmakoloji.2001;11:230-235. 2002 yılına ait yayınlar 29.Durmuş E, Oz G, Mutlu N, Oz F, Herken H. Nokturnal Bruksizmde Psikolojik Faktörlerin Rolü. Turk Oral Maksillo Fasiyal Cer. Derg. 2002;6:1-8. 30.Mutlu N, Herken H, Güray E, Öz F, Kalaycı A. Evaluation of the prevalence of temporomandibular joint disorder syndrome in dental school students with psychometric analysis. Turk J Med Sci 2002;32:345-350. 31.Erdal N, Erdal ME, Çamdeviren H, Gökdoğan T, Herken H. Bir Grup Sağlıklı Gönüllüde Katekol-O-Metiltransferaz (Comt) Gen Polimorfizmi Klinik Psikofarmakoloji.2002;12:174-179. 32.Herken H, Erdal ME, Esgi K, Vırıt O, Aynacıoğlu AS. The relationship between the response to risperidone treatment and 5-HT2A receptor gene (T102C and 1438G/A) polymorphism in schizophrenia. Klinik Psikofarmakoloji Bülteni 2003; 13:161-166. 33.Erdal N, Erdal M, Çamdeviren H, Özkaya M, Gökdoğan T, Herken H. Sağlıklı bireylerde Monoaminoksidaz-A gen polimorfizmi. Yeni Symposium 2003;41:185-189.
b.	1.Herken H, Çilli AS. SSRI’lara bağlı nokturnal bruksizm. Editöre mektup. Genel Tıp Dergisi 1998;2:91. 2.Kucur R, Kaya N, Herken H, Oğuz H. Ağrı bozukluğunun tedavisi bir vaka sebebiyle. S.Ü.T.F Dergisi 1994;10:91-94. 3.Kaya N, Altuğ B, Herken H, Kucur R. Görme Kaybıyla Seyreden Bir Konversiyon Olgusu. S.Ü.T.F Dergisi 1994;10:753-754. 4.Gergerlioğlu HS, Herken H, Uysal H. Panik Bozukluğun nörobiyiolojisi:CO2 kışkırtma testi Genel Tıp Dergisi 1998;3:133-137. 5.Herken H, Özkan İ. Sigara alışkanlığı ve anne-baba tutumu. Genel Tıp Dergisi1998;2:85-89. 6.Herken H, Özkan İ. Sigara ve Sosyal öğrenme, Genel Tıp Dergisi. 1998;1:45-47. 7.Aşkın R, Herken H. SSRIs and Unusual Side Effects. Klinik Psikofarmakoloji Bülteni 1998;4:249-250. 8.Herken H, Kaya N,Aşkın R, Kucur R. Nöroleptik malign sendrom: 5 olgu: Klinik psikiyatri 1998;2:120-124. 9.Herken H, Olcay HZ, Esgi K, Aynacıoğlu AŞ. Sitalopram alımının ardından şiddetli yan etkiler gelişen üç olgunun sitokrom P450 2C19 ve 3A4 açısından değerlendirilmesi. Klinik Psikiyatri 2000;3:197-203. 10.Erdal E, Herken H, Barlas Ö, Erdal N. Türk Toplumunda serotonin transporter gen polimorfizmi. Klinik Psikiyatri 2000;3:192-197. 11.Herken H. Farmakogenetik ve gelecekte vadettikleri. 3P 2004;12:95-114. 12.Herken H. Depresyonun Etyolojisinde Genetik Kanıtlar. Klinik Psikiyatri. 2002;5:5-11 13.Sırmatel F, Saygı G, Herken H, Bakır M, Dökmetaş I, Sırmatel O. Bir yapay bozukluk yada yalancı parazitoz olgusu. 2002;24:201-208.
Ulusal Atıflar
a.
b.
c.
A.3. madde dışında kalan uluslararası ve ulusal kongrelerde sunulan ve tam metni veya özeti yayınlanmış, sözlü veya poster bildiriler (basılı olması veya CD şeklinde yayınlanmış olması gerekir)
a.
b.
c.
d.
a.
b.
c.
d.
e.
A.11
A.12
Internet ortamında yayınlanan(Ulusal veya uluslararası)
a.
b.
c.
d.
e.
f.
Sanatsal Etkinlikler (Güzel Sanatlar) (Etkinliklerin eser listesi, davetiye, afiş, katalog vb. ile belgelendirilmesi gerekir. )
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Sanatsal Etkinlikler (Müzik) (Etkinliklerin eser listesi, davetiye, afiş vb. ile belgelendirilmesi gerekir. )
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Ulusal
Uluslararası
Spor Bilimleri-Uygulama
a.
b.
c.
d.
e.
f.
g.
h.
i.
j.
B	KONGRELER
B.1
B.2	Hasan Herken (Başkan Gursoy S) ‘AĞRIDA PSİKİYATRİK YAKLAŞIM’ Fiziksel Tıp ve Rehabilitasyon Günleri ‘Ağrı ve Tedavisi’ 6-8 Ekim 2000. Gaziantep. Hasan Herken ‘GENETİK ÇALIŞMALARIN PSİKİYATRİK HASTALIKLARIN ETYOLOJİSİNİN BELİRLENMESİ VE İLAÇ TEDAVİSİNDEKİ YERİ VE ÖNEMİ’ Bahar Sempozyumları 5. 24-29 Nisan 2001. Antalya. Hasan Herken (Başkan Yazıcı O) Konuşmacılar Bekir Sıtkı Şaylı ‘BAZI PSİKİYATRİK HASTALIKLARA YATKINLIK OLUŞTURDUĞU ÖNE SÜRÜLEN RESEPTÖR VE ENZİM POLİMORFİZMLERİ İLE BUNLARIN İLAÇ TEDAVİLERİNE ETKİLERİ’ 10. Anadolu Psikiyatri Günleri. 26-30 Haziran 2001. Abant Bolu. Hasan Herken, (Başkan Cem Atbaşoğlu) ŞİZOFRENİDE YENİ ARAŞTIRMA BULGULARI. 4. Ulusal Biyolojik Psikiyatri Kongresi. 7-11 Mayıs 2003. Ankara. Hasan Herken, (Başkan Hasan Herken) ‘ŞİZOFRENİNİN GENETİĞİNDE NELER YAPILDI, NELER YAPILABİLİR’ 39. Ulusal Psikiyatri Kongresi. 14-19 Ekim 2003. Antalya. Hasan Herken ‘ŞİZOFRENİDE FARMAKOGENETİK ARAŞTIRMALAR’39. Ulusal Psikiyatri Kongresi. 14-19 Ekim 2003. Antalya. Hasan Herken (Başkan K. Alptekin) ‘ANTPSİKOTİK TEDAVİYE YANIT ÖNCEDEN BİLİNEBİLİR Mİ?’ 13. Anadolu Psikiyatri Günleri. 19-22 Mayıs 2004. Gaziantep. Hasan Herken (Başkan Işık E). Hamile kalma talebi ile gelen psikoz hastasına yaklaşımda etik, genetik, kaygılar ve hekimin rolü. 8. Gazi Günleri. 7-11 Nisan 2004. Gazi Mağusa Kıbrıs. Hasan Herken. Psikotrop ilaç etkileşmeleri. Psikosomatik Tıp Buluşmaları. 7-8 Mayıs İstanbul 2007. Hasan Herken. Nikotin Bağımlılığın Genetiği . Türk Toraks Derneği. Eylül 2006. İstanbul
B.3
B.4	Hasan Herken (Başkan Uluğ B)‘BİLİMSEL MAKALE YAZMAK VE YAYINLATMAK’ Bahar Sempozyumları 6. 24-28 Nisan 2002. Antalya. Hasan Herken (Başkan Örnek T)‘PSİKİYATRİ VE GENETİK’ 38. Ulusal Psikiyatri Kongresi 22-27 Ekim 2002 Marmaris. Hasan Herken, PROJE YAPMAK BURS ALMAK DENEYİM PAYLAŞIMI.8. Bahar Sepozyumu. 14-18 Nisan 2004. 2004 Antalya. Hasan Herken (Başkan Tezcan E)‘MAKALE YAZMAK VE YAYINLATMAK’ 9. Ulusal Sosyal Psikiyatri Kongresi. 11-14 Haziran 2002 Malatya.
B.5	American psychiatric Association Annual Meeting 2003 American psychiatric Association Annual Meeting 2004 American psychiatric Association Annual Meeting 2006 American psychiatric Association Annual Meeting 2007
B.6
C.	HAKEMLİK VE EDİTÖRLÜK
a.
b.
c.	Archives Of General Psychiarty Comprehensive Psychiatry Neurosci Letter Psychiatry Research The Pharmacogenetics Journal
a.
b.
c.
C.3
C.4
a.
b.
D	EĞİTİM VE ARAŞTIRMA
a.
b.
c.
d.
e.
f.
g.
h.
ı.
i.
j.
k.
D.2
Sonuçlandırılmış tez yönetim puanı
a.
b.	Dr. Osman Vırıt. Türk Şizofreni Hastalarında ACE Gen Polimorfizmi 2004.
c.
Kredili sistem
Kredisiz sistem		Tıp Fakültesi Dönem I Davranış Bilimleri 2003 (İki Dönem) Tıp Fakültesi Dönem 1 Davranış Biimleri 2004 (iki Dönem) Tıp Fakültesi Dönem III Psikiyatrik Semiyoloji 2003 (Bir dönem) Tıp Fakültesi Donem III Psikiyatrik Semiyoloji 2004 (Bir dönem) Sağlık Meslek Yüksek okulu Hemşirelik Bölümü (Bir dönem)
b.	Dönem III Psikoz modül sorumluluğu 2007 Dönem III Eğitim Yönlendiricisi 13. Modül kaderin ağı 2007 Dönem III Eğitim Yönlendiricisi 14. Modül Yanar dönemez 2007 Dönem III Eğitim Yönlendiricisi 15. Modül Dağılma 2007 Donem 5 Anksiyete OKB TASKs orumluluğu
c.
d.
e.
f.
g.	Stigma Hasan Herken 2005. Şizofrenide Ayırıcı tanı 2005. İletişim Becerileri Psikotik hastaya yaklaşım, görüşme, Hasan Herken 2007 Şizofrenide zorla tedavi Hasan Herken 2007
	h.
D.5
Uluslararası sempozyum, kongre, çalıştay, gibi etkinliklerde;
I.
II.
Ulusal sempozyum, kongre, çalıştay, gibi etkinliklerde;
I.
II.
Kendi uzmanlık dalı veya doktora yaptığı alan dışındaki başka bir alanda
a.
b.
a.
b.
E	ÖDÜLLER VE PATENTLER
Ödül puanları (yayın teşvik ödülleri hariç, araştırmacılar arasında eşit paylaştırılır)
a.
b.	1-Myofasiyal Ağrı Sendromu ile Serotonin Transporter Gen Polimorfizmi Arası İlişki’ isimli çalışmam ile 36. Ulusal Psikiyatri Kongresinde Psikiyatri Derneği araştırma birincilik ödülü verilmiştir 2001. 2-Herken H, Emin Erdal ME. Catechol-O-Methyltransferase Gene Polymorphism In Schizophrenia: An Evidence For Associatıon Between Symptomatology And Prognosis. 3. Ulusal Biyolojik Psikiyatri bilimsel kurulunca poster ödülü verilmiştir. 3- Herken H, Aynacıoğlu AŞ, Koray Esgi, Vırıt O. Psikiyatri Hastalarında Sitokrom P 450 2D6 Enzim Hızları. 2001 yılı Türk Psikiyatri Dergisi Araştırma ödülü verilmiştir. 4-Zoroğlu S, Herken H ver ark..Şizofreni hastalarında nitrik oksit ve adrenomedullin düzeyleri ve hastalığın kliniği ile ilişkisi isimli çalışması 6. Bahar Sempozyumlarında araştırma birincilik ödülü almıştır.2003 5– Savaş HA, Herken H ve ark. Savaş Bipolar duygudurum Bozukluklu hastalarda nitrik oksit ve adrenomedullin düzeylerinin hastalığın patofizyolojisindeki rolü isimli çalışması 6. Bahar Sempozyumlarında duygudurum araştırmaları arasında araştırma ikincilik ödülü almıştır. 6.Dr.Hasan HERKEN1,3, Dr. Emin ERDAL2, Dr.Murat Eren ÖZEN1, M. Cemal KAYA.DEPRESYON HASTALARINDA TRİPTOFAN HİDROKSİLAZ GEN ve SEROTONİN TAŞIYICI GEN POLİMORFİZMİNİN ANTİDEPRESAN TEDAVİ YANITLA İLİŞKİSİ. Araştırma İkincilik Ödülü. 1. Ulusal Psikofarmakoloji Kongresi 2005. 7–Herken H, Erdal ME, Esgi K ve ark. Şizofreni tedavisinde risperidon tedavisine yanit ile 5HT2A reseptor gen polimorfizmi arası ilişki. 38. Ulusal Psikiyatri Kongresinde Psikiyatri Derneği araştırma birincilik ödülü verilmiştir.2002. 8- Herken H, Uz E, Özyurt H,Söğüt S, Vırıt O, Akyol Ö. Evidence That The Activities Of Erythrocyte Free Radical Scavenging Enzymes And The Products Of Lipid Peroxidation Are Increased In Different Forms Of Schizophrenia. Oğuz Arkonaç Şizofreni araştırma birincilik ödülü. 2002. 9-Barlas Ö, Savas HA, Arslan A, Herken H, ve ark. ‘Bipolar Bozukluklu hastalarda serotonin taşıyıcı gen polimorfizmi’ 38. Ulusal Psikiyatri Kongresinde Duygudurum Bozuklukları araştırma birincilik ödülü verilmiştir.2002. 10-Çatololuk O, Nacak M, Savaş O, Tutkun H. Zoroğlu S, Herken H, Barlas O, Özen ME, Arslan A.Bipolar hastalarda ACE enzim gen olimorfizmi 5. Bakırköy Psikiyatri Günleri Araştırma birincilik Ödülü verimiştir.2003. 11.Hasan Herken, ve ark.. Olanzapine bağlı kilo alımında peroxsizom proliferatör activated reseptör pro12Ala polimorfizminin etkisi. En İyi Çalışma Ödülü 11. Gazi Psikiyatri Günleri. 2007. 12.Hasan Herken,M. Emin Erdal.Mesut Çetin⁴, Ömer Barlas³, Cengiz Basoglu⁴, Özcan Uzun⁵, Tuba Gökdoğan³HT2A RESEPTÖR GENİNİN T102C ve 1438G/A POLİMORFİZMLERİ İLE KLOZAPİN TEDAVİSİNE YANIT ARASI İLİŞKİ. Ulusal Psikiyatri Kongresi Poster ödülü. Erzurum. 2005.
c.
Patent puanı
a.
b.
E.3
F	AKADEMİK GÖREVLER
a.
b.
c.
d.
e.
TÜBİTAK, Milli Olimpiyat Komitesin’de görevlendirmeler
a.
b.
c.
d.
e.
G	TOPLUMSAL KATKI
a.
b.
c.
d.
	e.
H	İDARİ GÖREVLER
a.
b.
c.
d.
e.
f.
g.
h.
ı.
i.	Gaziantep Üniverstitesi Fakülte Kurulu Üyeliği Doçent temsilcisi (2002-2005)
j.	Gaziantep Üniverstitesi Fakülte Yönetim Kurulu Üyeliği Doçent temsilcisi (2002-2005)
k.
l.
m.

Prof. Dr. Hasan Herken Muayenehanesi

Adres

Randevu telefonları:

0258 242 63 93

E-posta:

Çalışma saatleri

Harita